JP2507158C - - Google Patents
Info
- Publication number
- JP2507158C JP2507158C JP2507158C JP 2507158 C JP2507158 C JP 2507158C JP 2507158 C JP2507158 C JP 2507158C
- Authority
- JP
- Japan
- Prior art keywords
- drug
- skin
- absorption
- preparation
- transdermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 claims description 102
- 239000003814 drug Substances 0.000 claims description 86
- 229940079593 drugs Drugs 0.000 claims description 84
- -1 polyoxyethylene Polymers 0.000 claims description 75
- 238000010521 absorption reaction Methods 0.000 claims description 66
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 41
- 239000000853 adhesive Substances 0.000 claims description 39
- 230000001070 adhesive Effects 0.000 claims description 39
- 239000002202 Polyethylene glycol Substances 0.000 claims description 33
- 229920001223 polyethylene glycol Polymers 0.000 claims description 33
- 239000003623 enhancer Substances 0.000 claims description 24
- 230000002708 enhancing Effects 0.000 claims description 24
- 210000003491 Skin Anatomy 0.000 description 62
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- 239000000243 solution Substances 0.000 description 31
- 239000000178 monomer Substances 0.000 description 29
- 239000000203 mixture Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 20
- 206010040880 Skin irritation Diseases 0.000 description 19
- 239000003795 chemical substances by application Substances 0.000 description 19
- 231100000475 skin irritation Toxicity 0.000 description 19
- 230000036556 skin irritation Effects 0.000 description 19
- 239000007787 solid Substances 0.000 description 18
- 206010015150 Erythema Diseases 0.000 description 14
- 231100000321 erythema Toxicity 0.000 description 14
- 239000003655 absorption accelerator Substances 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 229920000139 polyethylene terephthalate Polymers 0.000 description 8
- 239000005020 polyethylene terephthalate Substances 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- 239000003522 acrylic cement Substances 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- CGIGDMFJXJATDK-UHFFFAOYSA-N Indometacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 6
- 229960000201 Isosorbide Dinitrate Drugs 0.000 description 6
- MOYKHGMNXAOIAT-JGWLITMVSA-N Isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 229920001971 elastomer Polymers 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- UUWJHAWPCRFDHZ-UHFFFAOYSA-N 1-dodecoxydodecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC UUWJHAWPCRFDHZ-UHFFFAOYSA-N 0.000 description 4
- QYSPLQLAKJAUJT-UHFFFAOYSA-N Piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene (PE) Substances 0.000 description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- 239000005038 ethylene vinyl acetate Substances 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000001965 increased Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 239000012466 permeate Substances 0.000 description 4
- 229960002702 piroxicam Drugs 0.000 description 4
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (Z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- 230000036868 Blood Concentration Effects 0.000 description 3
- 229960005309 Estradiol Drugs 0.000 description 3
- 229960000905 Indomethacin Drugs 0.000 description 3
- 230000036740 Metabolism Effects 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- HYIMSNHJOBLJNT-UHFFFAOYSA-N Nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 3
- 229960001597 Nifedipine Drugs 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 229920001083 Polybutene Polymers 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000035786 metabolism Effects 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 3
- 230000001737 promoting Effects 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N (E)-but-2-enedioate;hydron Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- 229940005530 ANXIOLYTICS Drugs 0.000 description 2
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 2
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 2
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 2
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 2
- 206010003119 Arrhythmia Diseases 0.000 description 2
- 208000006673 Asthma Diseases 0.000 description 2
- 230000036912 Bioavailability Effects 0.000 description 2
- 206010007521 Cardiac arrhythmias Diseases 0.000 description 2
- 229960001347 Fluocinolone Acetonide Drugs 0.000 description 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N Fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 2
- SYTBZMRGLBWNTM-UHFFFAOYSA-N Flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 2
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 description 2
- 229960002479 Isosorbide Drugs 0.000 description 2
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 2
- 210000004185 Liver Anatomy 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N Maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 2
- 229940046008 Vitamin D Drugs 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- 125000005396 acrylic acid ester group Chemical group 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 201000005794 allergic hypersensitivity disease Diseases 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 230000000202 analgesic Effects 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000000954 anitussive Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000003699 antiulcer agent Substances 0.000 description 2
- 230000000949 anxiolytic Effects 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- 230000035514 bioavailability Effects 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000002490 cerebral Effects 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- IMROMDMJAWUWLK-UHFFFAOYSA-N ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 2
- 229960002390 flurbiprofen Drugs 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000000147 hypnotic Effects 0.000 description 2
- 239000003326 hypnotic agent Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940079866 intestinal antibiotics Drugs 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-L maleate(2-) Chemical compound [O-]C(=O)\C=C/C([O-])=O VZCYOOQTPOCHFL-UPHRSURJSA-L 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229920001195 polyisoprene Polymers 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000018040 scab formation Effects 0.000 description 2
- 231100000486 side effect Toxicity 0.000 description 2
- 231100000245 skin permeability Toxicity 0.000 description 2
- 239000002294 steroidal antiinflammatory agent Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000000261 vasodilator Effects 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- RSLNRVYIRDVHLY-MERQFXBCSA-N (1R)-2-(tert-butylamino)-1-(2-chlorophenyl)ethanol;hydrochloride Chemical compound Cl.CC(C)(C)NC[C@H](O)C1=CC=CC=C1Cl RSLNRVYIRDVHLY-MERQFXBCSA-N 0.000 description 1
- YGULWPYYGQCFMP-NPHUUBOGSA-N (2R,3S)-2,3-dihydroxybutanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1.COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 YGULWPYYGQCFMP-NPHUUBOGSA-N 0.000 description 1
- BPXZSHHCUKRDHD-HTLUESNNSA-N (E)-but-2-enedioic acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide;hydrate Chemical compound O.OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 BPXZSHHCUKRDHD-HTLUESNNSA-N 0.000 description 1
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N 1,2,3-propanetrioltrinitrate Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N 1,6-Hexanediol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N 2-((2,6-Dichlorophenyl)imino)imidazolidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- RSNDTPFSMDVWCS-UHFFFAOYSA-N 2-(butoxymethyl)prop-2-enamide Chemical compound CCCCOCC(=C)C(N)=O RSNDTPFSMDVWCS-UHFFFAOYSA-N 0.000 description 1
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 1
- XCESYZPOWKEXHF-UHFFFAOYSA-N 2-(ethoxymethyl)prop-2-enamide Chemical compound CCOCC(=C)C(N)=O XCESYZPOWKEXHF-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- RJPWESHPIMRNNM-YDALLXLXSA-N 2-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]benzonitrile;hydrochloride Chemical compound Cl.CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C#N RJPWESHPIMRNNM-YDALLXLXSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N 2-methyl-2-propenoic acid methyl ester Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- KFTHUBZIEMOORC-UHFFFAOYSA-N 2-methylbut-2-enamide Chemical compound CC=C(C)C(N)=O KFTHUBZIEMOORC-UHFFFAOYSA-N 0.000 description 1
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 description 1
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 description 1
- CPBZARXQRZTYGI-UHFFFAOYSA-N 3-cyclopentylpropylcyclohexane Chemical compound C1CCCCC1CCCC1CCCC1 CPBZARXQRZTYGI-UHFFFAOYSA-N 0.000 description 1
- UVRCNEIYXSRHNT-UHFFFAOYSA-N 3-ethylpent-2-enamide Chemical compound CCC(CC)=CC(N)=O UVRCNEIYXSRHNT-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- QNVKOSLOVOTXKF-UHFFFAOYSA-N 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;hydron;chloride Chemical compound Cl.NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1 QNVKOSLOVOTXKF-UHFFFAOYSA-N 0.000 description 1
- LZFSKNPPWIFMFL-UHFFFAOYSA-N 4-[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one Chemical compound C1CC(O)(C=2C=C(C(Cl)=CC=2)C(F)(F)F)CCN1CCCC(=O)C1=CC=C(F)C=C1 LZFSKNPPWIFMFL-UHFFFAOYSA-N 0.000 description 1
- AIKVCUNQWYTVTO-UHFFFAOYSA-N 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydron;chloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 AIKVCUNQWYTVTO-UHFFFAOYSA-N 0.000 description 1
- XXDAXBZYUXLDRD-SBSPUUFOSA-N 5-[2-[(2R)-3-(tert-butylamino)-2-hydroxypropyl]sulfanyl-1,3-thiazol-4-yl]thiophene-2-carboxamide;hydrochloride Chemical compound Cl.S1C(SC[C@H](O)CNC(C)(C)C)=NC(C=2SC(=CC=2)C(N)=O)=C1 XXDAXBZYUXLDRD-SBSPUUFOSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N 5-flurouricil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- SAPGBCWOQLHKKZ-UHFFFAOYSA-N 6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCOC(=O)C(C)=C SAPGBCWOQLHKKZ-UHFFFAOYSA-N 0.000 description 1
- NQSLZEHVGKWKAY-UHFFFAOYSA-N 6-methylheptyl 2-methylprop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C(C)=C NQSLZEHVGKWKAY-UHFFFAOYSA-N 0.000 description 1
- DXPPIEDUBFUSEZ-UHFFFAOYSA-N 6-methylheptyl prop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C=C DXPPIEDUBFUSEZ-UHFFFAOYSA-N 0.000 description 1
- COCLLEMEIJQBAG-UHFFFAOYSA-N 8-methylnonyl 2-methylprop-2-enoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)=C COCLLEMEIJQBAG-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 229940035676 ANALGESICS Drugs 0.000 description 1
- 229940005513 ANTIDEPRESSANTS Drugs 0.000 description 1
- 229940022659 Acetaminophen Drugs 0.000 description 1
- 229940022663 Acetate Drugs 0.000 description 1
- OFHCOWSQAMBJIW-AVJTYSNKSA-N Alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 1
- 229960002535 Alfacalcidol Drugs 0.000 description 1
- 229960000985 Ambroxol hydrochloride Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N Amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 229960005119 Amitriptyline Hydrochloride Drugs 0.000 description 1
- VIROVYVQCGLCII-UHFFFAOYSA-N Amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 1
- 229960001301 Amobarbital Drugs 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229950010731 Arotinolol Drugs 0.000 description 1
- 229960002274 Atenolol Drugs 0.000 description 1
- 229960004335 Azelastine hydrochloride Drugs 0.000 description 1
- BYFMCKSPFYVMOU-UHFFFAOYSA-N Bendazac Chemical compound C12=CC=CC=C2C(OCC(=O)O)=NN1CC1=CC=CC=C1 BYFMCKSPFYVMOU-UHFFFAOYSA-N 0.000 description 1
- 229960005274 Benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N Benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- XWTYSIMOBUGWOL-UHFFFAOYSA-N Bricaril Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- VMIYHDSEFNYJSL-UHFFFAOYSA-N Bromazepam Chemical compound C12=CC(Br)=CC=C2NC(=O)CN=C1C1=CC=CC=N1 VMIYHDSEFNYJSL-UHFFFAOYSA-N 0.000 description 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N Buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 1
- 229960001889 Buprenorphine hydrochloride Drugs 0.000 description 1
- 229960001590 Butorphanol Tartrate Drugs 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N Captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229920002301 Cellulose acetate Polymers 0.000 description 1
- 229960005091 Chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N Chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N Cholic acid Chemical class C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960004703 Clobetasol Propionate Drugs 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N Clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 229950002165 Clofluperol Drugs 0.000 description 1
- 229960002925 Clonidine Hydrochloride Drugs 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N Cromoglicic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N Crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 229960003957 Dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N Dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N Diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960001193 Diclofenac Sodium Drugs 0.000 description 1
- HHJIUUAMYGBVSD-YTFFSALGSA-N Difluocortolone valerate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)COC(=O)CCCC)[C@@]2(C)C[C@@H]1O HHJIUUAMYGBVSD-YTFFSALGSA-N 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N Diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 229960000525 Diphenhydramine Hydrochloride Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N Dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 229960002768 Dipyridamole Drugs 0.000 description 1
- UVTNFZQICZKOEM-UHFFFAOYSA-N Disopyramide Chemical compound C=1C=CC=NC=1C(C(N)=O)(CCN(C(C)C)C(C)C)C1=CC=CC=C1 UVTNFZQICZKOEM-UHFFFAOYSA-N 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 229960002061 Ergocalciferol Drugs 0.000 description 1
- AVOLMBLBETYQHX-UHFFFAOYSA-N Etacrynic acid Chemical compound CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl AVOLMBLBETYQHX-UHFFFAOYSA-N 0.000 description 1
- 229960002541 Ethacrynic Acid Drugs 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- VMZUTJCNQWMAGF-UHFFFAOYSA-N Etizolam Chemical compound S1C(CC)=CC2=C1N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl VMZUTJCNQWMAGF-UHFFFAOYSA-N 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N Famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 Famotidine Drugs 0.000 description 1
- ZPAKPRAICRBAOD-UHFFFAOYSA-N Fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 1
- UUOUOERPONYGOS-CLCRDYEYSA-N Fluocinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3C[C@H](F)C2=C1 UUOUOERPONYGOS-CLCRDYEYSA-N 0.000 description 1
- 229960002949 Fluorouracil Drugs 0.000 description 1
- 229960004580 GLIBENCLAMIDE Drugs 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N Glibenclamide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
- BOVGTQGAOIONJV-UHFFFAOYSA-N Gliclazide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1CC2CCCC2C1 BOVGTQGAOIONJV-UHFFFAOYSA-N 0.000 description 1
- 229960000346 Gliclazide Drugs 0.000 description 1
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 1
- WDZVGELJXXEGPV-YIXHJXPBSA-N Guanabenz Chemical compound NC(N)=N\N=C\C1=C(Cl)C=CC=C1Cl WDZVGELJXXEGPV-YIXHJXPBSA-N 0.000 description 1
- 229960003050 Guanabenz Acetate Drugs 0.000 description 1
- INJOMKTZOLKMBF-UHFFFAOYSA-N Guanfacine Chemical compound NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl INJOMKTZOLKMBF-UHFFFAOYSA-N 0.000 description 1
- 229960004746 Guanfacine Hydrochloride Drugs 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960002897 Heparin Drugs 0.000 description 1
- 240000008528 Hevea brasiliensis Species 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- UYNVMODNBIQBMV-UHFFFAOYSA-N Ifenprodil Chemical compound C1CC(CC=2C=CC=CC=2)CCN1C(C)C(O)C1=CC=C(O)C=C1 UYNVMODNBIQBMV-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N Ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960003630 Ketotifen Fumarate Drugs 0.000 description 1
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229940039717 Lanolin Drugs 0.000 description 1
- 229960005015 Local anesthetics Drugs 0.000 description 1
- 229940083877 Local anesthetics for treatment of hemorrhoids and anal fissures for topical use Drugs 0.000 description 1
- JSJCTEKTBOKRST-UHFFFAOYSA-N Mabuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(C(F)(F)F)=C1 JSJCTEKTBOKRST-UHFFFAOYSA-N 0.000 description 1
- 229950004407 Mabuterol Drugs 0.000 description 1
- QSLMDECMDJKHMQ-GSXCWMCISA-N Maprotiline Chemical compound C12=CC=CC=C2[C@@]2(CCCNC)C3=CC=CC=C3[C@@H]1CC2 QSLMDECMDJKHMQ-GSXCWMCISA-N 0.000 description 1
- 229960004992 Maprotiline Hydrochloride Drugs 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N Mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- HOKDBMAJZXIPGC-UHFFFAOYSA-N Mequitazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC1C(CC2)CCN2C1 HOKDBMAJZXIPGC-UHFFFAOYSA-N 0.000 description 1
- 230000035633 Metabolized Effects 0.000 description 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N Methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 1
- 229960001300 Metoprolol Tartrate Drugs 0.000 description 1
- 229960004843 Mianserin Hydrochloride Drugs 0.000 description 1
- 229960004857 Mitomycin Drugs 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- OMNKZBIFPJNNIO-UHFFFAOYSA-N N-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 description 1
- VWPOSFSPZNDTMJ-UCWKZMIHSA-N Nadolol Chemical compound C1[C@@H](O)[C@@H](O)CC2=C1C=CC=C2OCC(O)CNC(C)(C)C VWPOSFSPZNDTMJ-UCWKZMIHSA-N 0.000 description 1
- 229960004255 Nadolol Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N Naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229960002289 Nicardipine hydrochloride Drugs 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 229940014995 Nitroglycerin Drugs 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N Octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
- 229960004321 Pentaerithrityl tetranitrate Drugs 0.000 description 1
- 229960000968 Pentaerythritol Tetranitrate Drugs 0.000 description 1
- 239000000026 Pentaerythritol tetranitrate Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N Phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 Phenobarbital Drugs 0.000 description 1
- 229960002895 Phenylbutazone Drugs 0.000 description 1
- PHUTUTUABXHXLW-UHFFFAOYSA-N Pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001451 Polypropylene glycol Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 229960002386 Prazosin hydrochloride Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N Prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N Procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960002789 Procaterol Hydrochloride Drugs 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- RJKFOVLPORLFTN-STHVQZNPSA-N Progesterone Natural products O=C(C)[C@@H]1[C@@]2(C)[C@H]([C@H]3[C@@H]([C@]4(C)C(=CC(=O)CC4)CC3)CC2)CC1 RJKFOVLPORLFTN-STHVQZNPSA-N 0.000 description 1
- AQHHHDLHHXJYJD-UHFFFAOYSA-N Proprasylyt Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
- LOUPRKONTZGTKE-LHHVKLHASA-N Quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 1
- 229960004482 Quinidine Sulfate Drugs 0.000 description 1
- 240000000754 Rauvolfia serpentina Species 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N Scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 210000003802 Sputum Anatomy 0.000 description 1
- 210000004003 Subcutaneous Fat Anatomy 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Syngestrets Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- VOKSWYLNZZRQPF-UHFFFAOYSA-N Talwin Chemical compound C1C2=CC=C(O)C=C2C2(C)C(C)C1N(CC=C(C)C)CC2 VOKSWYLNZZRQPF-UHFFFAOYSA-N 0.000 description 1
- WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical compound O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 description 1
- 229960005105 Terbutaline Sulfate Drugs 0.000 description 1
- 229960003604 Testosterone Drugs 0.000 description 1
- 229960002372 Tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N Tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229960002180 Tetracycline Drugs 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229960002117 Triamcinolone Acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N Triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 229960004846 Tulobuterol hydrochloride Drugs 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N Verapamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- DDNCQMVWWZOMLN-IRLDBZIGSA-N Vinpocetine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=C(C(=O)OCC)N5C2=C1 DDNCQMVWWZOMLN-IRLDBZIGSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Xylocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- ATMLPEJAVWINOF-UHFFFAOYSA-N acrylic acid acrylic acid Chemical compound OC(=O)C=C.OC(=O)C=C ATMLPEJAVWINOF-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- CJDRUOGAGYHKKD-OVXZWHIBSA-N ajmaline Chemical compound CN1C2=CC=CC=C2[C@@]2([C@@H]([C@H]34)O)[C@@H]1[C@@H]1C[C@H]3[C@H](CC)[C@@H](O)N1[C@H]4C2 CJDRUOGAGYHKKD-OVXZWHIBSA-N 0.000 description 1
- 229960004332 ajmaline Drugs 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003712 anti-aging Effects 0.000 description 1
- 230000002429 anti-coagulation Effects 0.000 description 1
- 230000001430 anti-depressive Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000002921 anti-spasmodic Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- YEJAJYAHJQIWNU-UHFFFAOYSA-N azelastine hydrochloride Chemical compound Cl.C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 YEJAJYAHJQIWNU-UHFFFAOYSA-N 0.000 description 1
- 229960005149 bendazac Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229960002729 bromazepam Drugs 0.000 description 1
- 229950008581 bunitrolol Drugs 0.000 description 1
- GMTYREVWZXJPLF-AFHUBHILSA-N butorphanol D-tartrate Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O.N1([C@@H]2CC3=CC=C(C=C3[C@@]3([C@]2(CCCC3)O)CC1)O)CC1CCC1 GMTYREVWZXJPLF-AFHUBHILSA-N 0.000 description 1
- SOGAXMICEFXMKE-UHFFFAOYSA-N butyl 2-methylprop-2-enoate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000002812 cholic acid derivative Substances 0.000 description 1
- 229940000425 combination drugs Drugs 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- VOLSCWDWGMWXGO-UHFFFAOYSA-N cyclobuten-1-yl acetate Chemical compound CC(=O)OC1=CCC1 VOLSCWDWGMWXGO-UHFFFAOYSA-N 0.000 description 1
- GUOJYIXWHMJFDM-UHFFFAOYSA-N decan-2-yl prop-2-enoate Chemical compound CCCCCCCCC(C)OC(=O)C=C GUOJYIXWHMJFDM-UHFFFAOYSA-N 0.000 description 1
- GTBGXKPAKVYEKJ-UHFFFAOYSA-N decyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C(C)=C GTBGXKPAKVYEKJ-UHFFFAOYSA-N 0.000 description 1
- FWLDHHJLVGRRHD-UHFFFAOYSA-N decyl prop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C=C FWLDHHJLVGRRHD-UHFFFAOYSA-N 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- JBSLOWBPDRZSMB-FPLPWBNLSA-N dibutyl (Z)-but-2-enedioate Chemical compound CCCCOC(=O)\C=C/C(=O)OCCCC JBSLOWBPDRZSMB-FPLPWBNLSA-N 0.000 description 1
- KPHWPUGNDIVLNH-UHFFFAOYSA-M diclofenac sodium Chemical compound [Na+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KPHWPUGNDIVLNH-UHFFFAOYSA-M 0.000 description 1
- 229960003970 diflucortolone valerate Drugs 0.000 description 1
- 229960004166 diltiazem Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 229960001066 disopyramide Drugs 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N dodecyl prop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- FQHMMOGHDWAXDI-WUQHHHCFSA-N ergoloid mesylate Chemical compound CS(O)(=O)=O.C([C@H]1[C@]2(O)O3)CCN1C(=O)[C@H](C)N2C(=O)[C@]3(C(C)C)NC(=O)[C@H]1CN(C)[C@H](CC=2C3=C4C=CC=C3NC=2)[C@@H]4C1 FQHMMOGHDWAXDI-WUQHHHCFSA-N 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229960003199 etacrynic acid Drugs 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229960004404 etizolam Drugs 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000003419 expectorant Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 229960001395 fenbufen Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229940043075 fluocinolone Drugs 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 229960000193 formoterol fumarate Drugs 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229960002462 glycopyrronium bromide Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- AEQDBKHAAWUCMT-CVHDTDHSSA-N hydron;8-hydroxy-5-[(1R,2S)-1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one;chloride Chemical compound Cl.N1C(=O)C=CC2=C1C(O)=CC=C2[C@@H](O)[C@@H](NC(C)C)CC AEQDBKHAAWUCMT-CVHDTDHSSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960000204 ifenprodil tartrate Drugs 0.000 description 1
- 230000001771 impaired Effects 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229940064003 local anesthetic throat preparations Drugs 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental Effects 0.000 description 1
- 229960005042 mequitazine Drugs 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- YNPFMWCWRVTGKJ-UHFFFAOYSA-N mianserin hydrochloride Chemical compound [H+].[Cl-].C1C2=CC=CC=C2N2CCN(C)CC2C2=CC=CC=C21 YNPFMWCWRVTGKJ-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 101700025122 nac-1 Proteins 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 1
- FSAJWMJJORKPKS-UHFFFAOYSA-N octadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C=C FSAJWMJJORKPKS-UHFFFAOYSA-N 0.000 description 1
- 229940065472 octyl acrylate Drugs 0.000 description 1
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960001735 pentaerythritol Drugs 0.000 description 1
- 229960005301 pentazocine Drugs 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 229960002508 pindolol Drugs 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 150000003097 polyterpenes Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- WFXFYZULCQKPIP-UHFFFAOYSA-N prazosin hydrochloride Chemical compound [H+].[Cl-].N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 WFXFYZULCQKPIP-UHFFFAOYSA-N 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- BZKBCQXYZZXSCO-UHFFFAOYSA-N sodium hydride Inorganic materials [H-].[Na+] BZKBCQXYZZXSCO-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 229960000744 vinpocetine Drugs 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N α-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
Description
ãçºæã®è©³çŽ°ãªèª¬æã
ïŒç£æ¥äžã®å©çšåéïŒ
æ¬çºæã¯ãç®èã«çŽæ¥è²Œä»ããŠæèŠã®è¬ç©ãäœå
埪ç°åšç³»ãžæäžããã®ã«äœ¿çš
ãããçµç®åžå補å€ã«é¢ãããã詳现ã«ã¯ãè¬ç©ããã³éæ°Žç³»ç²çæ§åºå€ããã
ã«ç®èã®ããªã¢ãŒæ©èœã匱ããŠè¬ç©ã®åžåãä¿ãåžåä¿é²å€ãå«ã貌ä»å±€ãæ¯æ
äœã«ä¿æããŠãªãçµç®åžå補å€ã«ãããŠè©²åžåä¿é²å€ã®æ¹è¯ã«é¢ãããã®ã§ãã
ã
ãããçµç®åžå補å€ã«é¢ãããã詳现ã«ã¯ãè¬ç©ããã³éæ°Žç³»ç²çæ§åºå€ããã
ã«ç®èã®ããªã¢ãŒæ©èœã匱ããŠè¬ç©ã®åžåãä¿ãåžåä¿é²å€ãå«ã貌ä»å±€ãæ¯æ
äœã«ä¿æããŠãªãçµç®åžå補å€ã«ãããŠè©²åžåä¿é²å€ã®æ¹è¯ã«é¢ãããã®ã§ãã
ã
ïŒåŸæ¥ã®æè¡ïŒ
åŸæ¥ãè¬ç©ãäœå
ãžæäžããéããã®å€åãšããŠãçµå£å€ã泚å°å€ãåå€ãªã©
ãé©å®æ¡çšãããŠããããè¿å¹Žãçµç®åžå補å€ã®éçºã以äžã®å©ç¹ã«ããç©æ¥µç
ã«é²ããããŠãããããªãã¡ãçµç®åžå補å€ã§ã¯ã äœå ã«åžåãããè¬ç©ãåå埪ç°ã§ã¯èèãééããªããããçµå£æäžæ³ã®
å Žåã®ããã«è žã§åžåãããè¬ç©ãèèãžåŸªç°ããŠä»£è¬ãåããã®è¬å¹ãæžéã
ããšããæ¬ ç¹ããªãã
ãé©å®æ¡çšãããŠããããè¿å¹Žãçµç®åžå補å€ã®éçºã以äžã®å©ç¹ã«ããç©æ¥µç
ã«é²ããããŠãããããªãã¡ãçµç®åžå補å€ã§ã¯ã äœå ã«åžåãããè¬ç©ãåå埪ç°ã§ã¯èèãééããªããããçµå£æäžæ³ã®
å Žåã®ããã«è žã§åžåãããè¬ç©ãèèãžåŸªç°ããŠä»£è¬ãåããã®è¬å¹ãæžéã
ããšããæ¬ ç¹ããªãã
泚å°å€ã«æ¯ã¹ããšæ£è
ã®ç²Ÿç¥çè² æ
ãèäœçèŠçãå°ãªãã
è¡äžæ¿åºŠãé·æéå¿
èŠã¬ãã«ã«ç¶æãããããé·æéã«ããã£ãŠé£ç¶æäžã
å¯èœã§ããã
å¯èœã§ããã
å¿
èŠã«å¿ããŠæäžã容æã«äžæãåŸãã
ãšããã§ããã®çš®ã®çµç®åžå補å€ã¯ãæ¬æ¥ç°ç©ã®äœå
ãžã®äŸµå
¥ãé²ãããªã€ãŒ
æ©èœãæããç®èã®è§è³ªå±€ãçµç±ããŠè¬ç©ãäœå 埪ç°åšç³»ãžæäžãããã®ã§ ãããããææã®è¬å¹ãçºçŸãããã«å åãªéã®è¬ç©ãæäžããã®ã¯å¿ ããã容
æã§ãªããéåžžã該補å€ã®è²Œä»é¢ç©ã倧ããããããåºå€ã«åžåä¿é²å€ãå ããŠ
è¬ç©ã®æŸåºæ§ãé«ãããªã©ã®å¯ŸçããšãããŠããã
æ©èœãæããç®èã®è§è³ªå±€ãçµç±ããŠè¬ç©ãäœå 埪ç°åšç³»ãžæäžãããã®ã§ ãããããææã®è¬å¹ãçºçŸãããã«å åãªéã®è¬ç©ãæäžããã®ã¯å¿ ããã容
æã§ãªããéåžžã該補å€ã®è²Œä»é¢ç©ã倧ããããããåºå€ã«åžåä¿é²å€ãå ããŠ
è¬ç©ã®æŸåºæ§ãé«ãããªã©ã®å¯ŸçããšãããŠããã
ããããçµç®åžå補å€ã¯ç®èãåºæ¿ãããšããå¯äœçšãæããŠããããã該補
å€ã®è²Œä»é¢ç©ã¯å¯èœãªéãå°ããæ¹ã奜ãŸãããããªãã¡ã該補å€ãç®èã«è²Œä»
ããŠããæéäžãç®èè¡šé¢ã«ã¯è©²è£œå€ã®è²Œä»å±€ãæ¥ããŠããããããã®éšåã®ç®
èã¯æ£åžžãªäœçšãããšãã°åæ³ã代è¬ã䌞瞮ãªã©ã劚ããããäžã«ã貌ä»å±€èªäœ
ããåžžã«åºæ¿ãåããããšã«ãªãããã®çµæãç®èã®è²Œä»éšã«çŽ æãçºçããã²
ã©ãå Žåã«ã¯çç®åœ¢æãæµ®è «åœ¢æã䌎ããçµç®åžå補å€ã®é€å»åŸãæ°æ¥éç¶ãã
ãšããããããããã£ãŠããã®ãããªå¯äœçšãäœæžãããããã«ã¯ãçµç®åžå補
å€ã®è²Œä»é¢ç©ã®çž®å°åãæãŸããã
å€ã®è²Œä»é¢ç©ã¯å¯èœãªéãå°ããæ¹ã奜ãŸãããããªãã¡ã該補å€ãç®èã«è²Œä»
ããŠããæéäžãç®èè¡šé¢ã«ã¯è©²è£œå€ã®è²Œä»å±€ãæ¥ããŠããããããã®éšåã®ç®
èã¯æ£åžžãªäœçšãããšãã°åæ³ã代è¬ã䌞瞮ãªã©ã劚ããããäžã«ã貌ä»å±€èªäœ
ããåžžã«åºæ¿ãåããããšã«ãªãããã®çµæãç®èã®è²Œä»éšã«çŽ æãçºçããã²
ã©ãå Žåã«ã¯çç®åœ¢æãæµ®è «åœ¢æã䌎ããçµç®åžå補å€ã®é€å»åŸãæ°æ¥éç¶ãã
ãšããããããããã£ãŠããã®ãããªå¯äœçšãäœæžãããããã«ã¯ãçµç®åžå補
å€ã®è²Œä»é¢ç©ã®çž®å°åãæãŸããã
åŸæ¥ããã貌ä»é¢ç©ã®çž®å°åãè¬ç©ã®çµç®åžåæ§åäžãç®çãšããŠåžåä¿é²å€
ãçš®ã ææ¡ãããŠããããã®ããã«ç¹å®ã®åžåä¿é²å€ã®æ·»å ã«ãã£ãŠè¬ç©ã®ç®è
ãžã®æŸåºæ§ãåäžãããæè¡ã®åŸæ¥äŸãšããŠã¯ãããšãã°ãåžåä¿é²å€ãšããŠã
ãªãªãã·ãšãã¬ã³ã©ãŠãªã«ãšãŒãã«ã§ä»£è¡šãããããªãªãã·ãšãã¬ã³ã¢ã«ãã«ãš
ãŒãã«ãçšãããã®ïŒç¹éæïŒïŒâïŒïŒïŒïŒïŒå·å ¬å ±åç §ïŒããéã€ãªã³æ§çé¢
掻æ§å€ãäž¡æ§çé¢æŽ»æ§å€ãé°ã€ãªã³æ§çé¢æŽ»æ§å€ãå€äŸ¡ã¢ã«ã³ãŒã«èèªé žãšã¹ã
ã«ã®å ã®äžçš®ãŸãã¯äºçš®ä»¥äžãåžåä¿é²å€ãšããŠçšãããã®ïŒç¹éæïŒïŒâïŒïŒ
ïŒïŒïŒïŒå·å ¬å ±åç §ïŒãã³ãŒã«é žèªå°äœããã³ãã©ã³é žèªå°äœããšã¿ã¯ãªã³é žã
ãã©ã¢ããå®æ¯éŠé žèªå°äœãã·ã§ç³èèªé žãšã¹ãã«ãããªãªãã·ãšãã¬ã³ãœã«ã
ã¿ã³èèªé žãšã¹ãã«ãããªãªãã·ãšãã¬ã³ã¢ã«ãã«ãšãŒãã«ãé°ã€ãªã³æ§çé¢æŽ»
æ§å€ãäž¡æ§çé¢æŽ»æ§å€ã®å ããéžã°ããåžåä¿é²å€ãçšãããã®ïŒç¹éæïŒïŒâ
ïŒïŒïŒïŒïŒïŒå·å ¬å ±åç §ïŒãããªãªãã·ãšãã¬ã³ã¢ããªã¬ãšãŒãã§ä»£è¡šãããé ž
åãšãã¬ã³ä»å åéã€ãªã³çé¢æŽ»æ§å€ãçšãããã®ïŒç¹éæïŒïŒâïŒïŒïŒïŒïŒå·
å ¬å ±åç §ïŒãªã©ãç¥ãããŠããã
ãçš®ã ææ¡ãããŠããããã®ããã«ç¹å®ã®åžåä¿é²å€ã®æ·»å ã«ãã£ãŠè¬ç©ã®ç®è
ãžã®æŸåºæ§ãåäžãããæè¡ã®åŸæ¥äŸãšããŠã¯ãããšãã°ãåžåä¿é²å€ãšããŠã
ãªãªãã·ãšãã¬ã³ã©ãŠãªã«ãšãŒãã«ã§ä»£è¡šãããããªãªãã·ãšãã¬ã³ã¢ã«ãã«ãš
ãŒãã«ãçšãããã®ïŒç¹éæïŒïŒâïŒïŒïŒïŒïŒå·å ¬å ±åç §ïŒããéã€ãªã³æ§çé¢
掻æ§å€ãäž¡æ§çé¢æŽ»æ§å€ãé°ã€ãªã³æ§çé¢æŽ»æ§å€ãå€äŸ¡ã¢ã«ã³ãŒã«èèªé žãšã¹ã
ã«ã®å ã®äžçš®ãŸãã¯äºçš®ä»¥äžãåžåä¿é²å€ãšããŠçšãããã®ïŒç¹éæïŒïŒâïŒïŒ
ïŒïŒïŒïŒå·å ¬å ±åç §ïŒãã³ãŒã«é žèªå°äœããã³ãã©ã³é žèªå°äœããšã¿ã¯ãªã³é žã
ãã©ã¢ããå®æ¯éŠé žèªå°äœãã·ã§ç³èèªé žãšã¹ãã«ãããªãªãã·ãšãã¬ã³ãœã«ã
ã¿ã³èèªé žãšã¹ãã«ãããªãªãã·ãšãã¬ã³ã¢ã«ãã«ãšãŒãã«ãé°ã€ãªã³æ§çé¢æŽ»
æ§å€ãäž¡æ§çé¢æŽ»æ§å€ã®å ããéžã°ããåžåä¿é²å€ãçšãããã®ïŒç¹éæïŒïŒâ
ïŒïŒïŒïŒïŒïŒå·å ¬å ±åç §ïŒãããªãªãã·ãšãã¬ã³ã¢ããªã¬ãšãŒãã§ä»£è¡šãããé ž
åãšãã¬ã³ä»å åéã€ãªã³çé¢æŽ»æ§å€ãçšãããã®ïŒç¹éæïŒïŒâïŒïŒïŒïŒïŒå·
å ¬å ±åç §ïŒãªã©ãç¥ãããŠããã
ïŒçºæã解決ãã¹ã課é¡ïŒ
åžåä¿é²å€ã¯ãçµç®åžå補å€ãç®èã«è²Œä»ããŠããæéäžãç®èã«å¯ŸããŠäœçš
ãããã®ã§ãããããç®èåºæ¿ãæãããã®ã§ãã£ãŠã¯ãªããªãã
ãããã®ã§ãããããç®èåºæ¿ãæãããã®ã§ãã£ãŠã¯ãªããªãã
ããããªãããäžèšåŸæ¥æè¡ã®çµç®åžå補å€ã«ãããŠäœ¿çšãããŠããåžåä¿
é²å€ã¯ã確ãã«çµç®åžåä¿é²å¹æãèªããããååç©ã§ã¯ããããããããç®è
åºæ¿ã匷ããšããé£ç¹ãæããŠãããããããäžè¬çã«åžåä¿é²å€ã¯çµç®åžåä¿
é²å¹æãé«ããã®ã»ã©ãç®èåºæ¿ã匷ãåŸåã«ãããããçµç®åžåä¿é²å¹æãé«
ãããã€ãç®èåºæ¿ã®äœãåžåä¿é²å€ã¯æªã éçºãããŠããªãã®ãçŸç¶ã§ããã
åºæ¿ã匷ããšããé£ç¹ãæããŠãããããããäžè¬çã«åžåä¿é²å€ã¯çµç®åžåä¿
é²å¹æãé«ããã®ã»ã©ãç®èåºæ¿ã匷ãåŸåã«ãããããçµç®åžåä¿é²å¹æãé«
ãããã€ãç®èåºæ¿ã®äœãåžåä¿é²å€ã¯æªã éçºãããŠããªãã®ãçŸç¶ã§ããã
æ¬çºæã®ç®çã¯ãäžèšã®åŠãå®æ
ã«éã¿ã貌ä»é¢ç©ãå°ãããŠãææã®è¬å¹ã
çºçŸãããã«å åãªéã®è¬ç©ãçµç®ééããããããšãã§ãããšå ±ã«ãåžåä¿é²
å€ã«ããç®èã®åºæ¿ãå¯åçã«äœæžããçµç®åžå補å€ãæäŸããã«ããã
çºçŸãããã«å åãªéã®è¬ç©ãçµç®ééããããããšãã§ãããšå ±ã«ãåžåä¿é²
å€ã«ããç®èã®åºæ¿ãå¯åçã«äœæžããçµç®åžå補å€ãæäŸããã«ããã
ïŒèª²é¡ã解決ããããã®æ段ïŒ
æ¬çºæã¯ãäžèšç®çãéæãã¹ãæ€èšãéããçµæãè¬ç©ããã³åžåä¿é²å€ã
å«ãç²çæ§åºå€å±€ãšåå±€ãä¿æããæ¯æäœãšãããªãïŒå±€ç³»ã«ãããŠã該åžåä¿
é²å€ãšããŠç¹å®ã®ïŒã€ã®ååç©ã䜵çšãããšãè¬ç©ã®çµç®ééæ§ãåäžãããšå ±
ã«ç®èåºæ¿ãæ®ã©ãªããå šããªããšããç¥èŠãåŸãŠå®æãããããã®ã§ããã
å«ãç²çæ§åºå€å±€ãšåå±€ãä¿æããæ¯æäœãšãããªãïŒå±€ç³»ã«ãããŠã該åžåä¿
é²å€ãšããŠç¹å®ã®ïŒã€ã®ååç©ã䜵çšãããšãè¬ç©ã®çµç®ééæ§ãåäžãããšå ±
ã«ç®èåºæ¿ãæ®ã©ãªããå šããªããšããç¥èŠãåŸãŠå®æãããããã®ã§ããã
ããªãã¡ãæ¬çºæã«ããçµç®åžå補å€ã¯ãéæ°Žç³»ç²çæ§åºå€ãšåžåä¿é²å€ãšè¬
ç©ãšãããªã貌ä»å±€ãæ¯æäœäžã«ä¿æããŠãªãçµç®åžå補å€ã«ãããŠã該åžåä¿
é²å€ãããªãªãã·ãšãã¬ã³èªå°äœãšããªãšãã¬ã³ã°ãªã³ãŒã«ãšãããªãããšãç¹
城ãšãããã®ã§ããã
ç©ãšãããªã貌ä»å±€ãæ¯æäœäžã«ä¿æããŠãªãçµç®åžå補å€ã«ãããŠã該åžåä¿
é²å€ãããªãªãã·ãšãã¬ã³èªå°äœãšããªãšãã¬ã³ã°ãªã³ãŒã«ãšãããªãããšãç¹
城ãšãããã®ã§ããã
æ¬çºæã«ããçµç®åžå補å€ã®æ§ææåã補é æ³ããã³é©çšæ³ã«ã€ããŠè©³ãã説
æããã
æããã
ïœïŒ æ¬çºæã«ããçµç®åžå補å€ã«ãããŠã¯ã該åžåä¿é²å€ãšããŠããªãªãã·ãš
ãã¬ã³èªå°äœãšããªãšãã¬ã³ã°ãªã³ãŒã«ã䜵çšããã
ãã¬ã³èªå°äœãšããªãšãã¬ã³ã°ãªã³ãŒã«ã䜵çšããã
ããªãªãã·ãšãã¬ã³èªå°äœã¯ãåºç¯å²ã®è¬ç©ã«å¯ŸããŠçµç®åžåä¿é²å€å¹æãæ
ããããšãç¥ãããŠããããé«ãåžåä¿é²å¹æãæåŸ ããã«ã¯ãããé«æ¿åºŠã§çš
ããå¿ èŠãããããã®çµæç®èåºæ¿ãç¡èŠã§ããªãã¬ãã«ãšãªãããããããã
ã«ããªãšãã¬ã³ã°ãªã³ãŒã«ã䜵çšãããšãäœæ¿åºŠã®ããªãªãã·ãšãã¬ã³èªå°äœã
çšããŠããé«ãåžåä¿é²å¹æãçºæ®ãããããã€ãç®èåºæ¿ãããªãªãã·ãšãã¬
ã³èªå°äœåç¬ã®å Žåãšæ¯èŒããŠäœäžãããã
ããããšãç¥ãããŠããããé«ãåžåä¿é²å¹æãæåŸ ããã«ã¯ãããé«æ¿åºŠã§çš
ããå¿ èŠãããããã®çµæç®èåºæ¿ãç¡èŠã§ããªãã¬ãã«ãšãªãããããããã
ã«ããªãšãã¬ã³ã°ãªã³ãŒã«ã䜵çšãããšãäœæ¿åºŠã®ããªãªãã·ãšãã¬ã³èªå°äœã
çšããŠããé«ãåžåä¿é²å¹æãçºæ®ãããããã€ãç®èåºæ¿ãããªãªãã·ãšãã¬
ã³èªå°äœåç¬ã®å Žåãšæ¯èŒããŠäœäžãããã
ããªãªãã·ãšãã¬ã³èªå°äœã®äŸãšããŠã¯ãããªãªãã·ãšãã¬ã³ã¢ããªã¬ã€ã³
é
žãšã¹ãã«ã«ä»£è¡šãããããªãªãã·ãšãã¬ã³ã¢ã«ãã«ãšã¹ãã«ãããªãªãã·ãšã
ã¬ã³ïŒïŒïŒïŒãªã¬ã€ã«ã¢ãã³ã«ä»£è¡šãããããªãªãã·ãšãã¬ã³ã¢ã«ãã«ã¢ãã³ã
ããªãªãã·ãšãã¬ã³ïŒïŒïŒïŒã©ãŠãªã«ãšãŒãã«ã«ä»£è¡šãããããªãªãã·ãšãã¬ã³
ã¢ã«ãã«ãšãŒãã«ãããªãªãã·ãšãã¬ã³ïŒïŒïŒïŒã¹ãã¢ãªã³é žã¢ããã«ä»£è¡šãã
ãããªãªãã·ãšãã¬ã³ã¢ã«ãã«ã¢ãããããªãªãã·ãšãã¬ã³ïŒïŒïŒã©ãŠãªã«ãšãŒ
ãã«ãªã³é žãããªãŠã ã«ä»£è¡šãããããªãªãã·ãšãã¬ã³ã¢ã«ãã«ãšãŒãã«ãªã³é ž
å¡©ãããªãªãã·ãšãã¬ã³ïŒïŒïŒãœã«ãã¿ã³ã¢ãã©ãŠã¬ãŒãã«ä»£è¡šãããããªãªã
ã·ãšãã¬ã³å€äŸ¡ã¢ã«ã³ãŒã«ã¢ã«ãã«ãšã¹ãã«ãªã©ãæãããããããªãªãã·ãšã
ã¬ã³ã¢ã«ãã«ãšãŒãã«ãªã³é žå¡©ãšããŠã¯äžèšã®ãã®ã®ã»ãã«ããªãªãã·ãšãã¬ã³
ïŒïŒïŒãªã¬ã€ã«ãšãŒãã«ãªã³é žãããªãŠã ããžããªãªãã·ãšãã¬ã³ïŒïŒïŒããã«
ãã§ãã«ãšãŒãã«ãªã³é žã«ãªãŠã ãªã©ãäŸç€ºãããããªããååç©åäžã®ã«ãã³
å ã®æ°å€ã¯ãªãã·ãšãã¬ã³åäœã®æ°ã瀺ãããããããªãªãã·ãšãã¬ã³èªå°äœã¯
ãè¬ç©ããã³ç²çæ§åºå€ã«å¿ããŠããã®ïŒã€ãåç¬ã§ããŸãã¯ãããã®ïŒçš®ä»¥äž
ãçµã¿åããã§é©å®äœ¿çšããããã
ã¬ã³ïŒïŒïŒïŒãªã¬ã€ã«ã¢ãã³ã«ä»£è¡šãããããªãªãã·ãšãã¬ã³ã¢ã«ãã«ã¢ãã³ã
ããªãªãã·ãšãã¬ã³ïŒïŒïŒïŒã©ãŠãªã«ãšãŒãã«ã«ä»£è¡šãããããªãªãã·ãšãã¬ã³
ã¢ã«ãã«ãšãŒãã«ãããªãªãã·ãšãã¬ã³ïŒïŒïŒïŒã¹ãã¢ãªã³é žã¢ããã«ä»£è¡šãã
ãããªãªãã·ãšãã¬ã³ã¢ã«ãã«ã¢ãããããªãªãã·ãšãã¬ã³ïŒïŒïŒã©ãŠãªã«ãšãŒ
ãã«ãªã³é žãããªãŠã ã«ä»£è¡šãããããªãªãã·ãšãã¬ã³ã¢ã«ãã«ãšãŒãã«ãªã³é ž
å¡©ãããªãªãã·ãšãã¬ã³ïŒïŒïŒãœã«ãã¿ã³ã¢ãã©ãŠã¬ãŒãã«ä»£è¡šãããããªãªã
ã·ãšãã¬ã³å€äŸ¡ã¢ã«ã³ãŒã«ã¢ã«ãã«ãšã¹ãã«ãªã©ãæãããããããªãªãã·ãšã
ã¬ã³ã¢ã«ãã«ãšãŒãã«ãªã³é žå¡©ãšããŠã¯äžèšã®ãã®ã®ã»ãã«ããªãªãã·ãšãã¬ã³
ïŒïŒïŒãªã¬ã€ã«ãšãŒãã«ãªã³é žãããªãŠã ããžããªãªãã·ãšãã¬ã³ïŒïŒïŒããã«
ãã§ãã«ãšãŒãã«ãªã³é žã«ãªãŠã ãªã©ãäŸç€ºãããããªããååç©åäžã®ã«ãã³
å ã®æ°å€ã¯ãªãã·ãšãã¬ã³åäœã®æ°ã瀺ãããããããªãªãã·ãšãã¬ã³èªå°äœã¯
ãè¬ç©ããã³ç²çæ§åºå€ã«å¿ããŠããã®ïŒã€ãåç¬ã§ããŸãã¯ãããã®ïŒçš®ä»¥äž
ãçµã¿åããã§é©å®äœ¿çšããããã
æ¬åžåä¿é²å€ã®ããŸïŒã€ã®æ§ææåã§ããããªãšãã¬ã³ã°ãªã³ãŒã«ãšããŠã¯ã
ååéïŒïŒïŒïŒïŒä»¥äžã®ãã®ã奜ãŸããã
ååéïŒïŒïŒïŒïŒä»¥äžã®ãã®ã奜ãŸããã
æ¬åžåä¿é²å€ã®é
åéã¯ãçµç®åžåä¿é²å¹æãå¹æçã«çºæ®ãããã«ã¯ãè¬ç©
ããã³ç²çæ§åºå€ã®çš®é¡ã«ãã£ãŠãç°ãªãããçµç®åžå補å€ã®è²Œä»å±€äžã«ïŒïŒïŒ
ãïŒïŒééïŒ ã®ç¯å²ã§ããããã®çç±ã¯ãåžåä¿é²å€ã®é åéãïŒïŒïŒééïŒ æª
æºã§ãããšææã®è¬å¹ãçºçŸãããã«å åãªéã®è¬ç©ãç®èãçµãŠäœå 埪ç°åšç³»
ã«åžåããããããšãã§ãããéã«åé åéãïŒïŒééïŒ ãè¶ãããšãçžå¯Ÿçã«
ç²çæ§åºå€ã®é åéãäœäžããŠç®èã«å¯Ÿãã補å€ã®è²Œä»æ§ãæªããªãããã§ãã
ãæ¬åžåä¿é²å€ã®ç¹ã«å¥œãŸããé åéã¯è²Œä»å±€äžã«ïŒïŒïŒãïŒïŒééïŒ ã®ç¯å²ã§
ããããŸããåžåä¿é²å€å šäœã«å¯Ÿããããªãšãã¬ã³ã°ãªã³ãŒã«ã®å²åã¯ãããªãª
ãã·ãšãã¬ã³èªå°äœã®çš®é¡ããã³éãè¬ç©ããã³ç²çæ§åºå€ã®çš®é¡ã«ãã£ãŠãç°
ãªãããïŒãïŒïŒééïŒ ã®ç¯å²ã§ããã奜ãŸããã¯ïŒïŒãïŒïŒééïŒ ã®ç¯å²ã§ã
ãã
ããã³ç²çæ§åºå€ã®çš®é¡ã«ãã£ãŠãç°ãªãããçµç®åžå補å€ã®è²Œä»å±€äžã«ïŒïŒïŒ
ãïŒïŒééïŒ ã®ç¯å²ã§ããããã®çç±ã¯ãåžåä¿é²å€ã®é åéãïŒïŒïŒééïŒ æª
æºã§ãããšææã®è¬å¹ãçºçŸãããã«å åãªéã®è¬ç©ãç®èãçµãŠäœå 埪ç°åšç³»
ã«åžåããããããšãã§ãããéã«åé åéãïŒïŒééïŒ ãè¶ãããšãçžå¯Ÿçã«
ç²çæ§åºå€ã®é åéãäœäžããŠç®èã«å¯Ÿãã補å€ã®è²Œä»æ§ãæªããªãããã§ãã
ãæ¬åžåä¿é²å€ã®ç¹ã«å¥œãŸããé åéã¯è²Œä»å±€äžã«ïŒïŒïŒãïŒïŒééïŒ ã®ç¯å²ã§
ããããŸããåžåä¿é²å€å šäœã«å¯Ÿããããªãšãã¬ã³ã°ãªã³ãŒã«ã®å²åã¯ãããªãª
ãã·ãšãã¬ã³èªå°äœã®çš®é¡ããã³éãè¬ç©ããã³ç²çæ§åºå€ã®çš®é¡ã«ãã£ãŠãç°
ãªãããïŒãïŒïŒééïŒ ã®ç¯å²ã§ããã奜ãŸããã¯ïŒïŒãïŒïŒééïŒ ã®ç¯å²ã§ã
ãã
iiïŒ æ¬çºæã®çµç®åžå補å€ã«äœ¿çšãããéæ°Žç³»ç²çæ§åºå€ã¯ãåžåä¿é²å€ãšã®
çžæº¶æ§ã«åªãã貌ä»å±€ã®è²Œçæ§ãæãªããããã€ã補å€ã®é·æå®å®æ§ãè¯å¥œ ãªãããããã®ã§ããã°ãç¹ã«éå®ãããªãã奜ãŸããéæ°Žç³»ç²çæ§åºå€ãšããŠ
ã¯ãã¢ã¯ãªã«ç³»ç²çæ§åºå€ããŽã ç³»ç²çæ§åºå€ãã·ãªã³ãŒã³ç³»ç²çæ§åºå€ãªã©ã
äŸç€ºãããã
çžæº¶æ§ã«åªãã貌ä»å±€ã®è²Œçæ§ãæãªããããã€ã補å€ã®é·æå®å®æ§ãè¯å¥œ ãªãããããã®ã§ããã°ãç¹ã«éå®ãããªãã奜ãŸããéæ°Žç³»ç²çæ§åºå€ãšããŠ
ã¯ãã¢ã¯ãªã«ç³»ç²çæ§åºå€ããŽã ç³»ç²çæ§åºå€ãã·ãªã³ãŒã³ç³»ç²çæ§åºå€ãªã©ã
äŸç€ºãããã
ã¢ã¯ãªã«ç³»ç²çæ§åºå€ãšããŠã¯ãç¹ã«ãççŽ æ°ïŒãïŒïŒã®èèªæã¢ã«ã³ãŒã«ãš
ïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšããåŸãããïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«ã®åç¬
éåäœãŸãã¯å ±éåäœããã³ïŒãŸãã¯äžèšïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«
ãšãã®ä»ã®å®èœæ§ã¢ãããŒãšã®å ±éåäœã奜é©ã«çšããããã
ïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšããåŸãããïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«ã®åç¬
éåäœãŸãã¯å ±éåäœããã³ïŒãŸãã¯äžèšïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«
ãšãã®ä»ã®å®èœæ§ã¢ãããŒãšã®å ±éåäœã奜é©ã«çšããããã
äžèšïŒã¡ã¿ïŒã¢ã¯ãªã«é
žãšã¹ãã«ãšããŠã¯ãã¢ã¯ãªã«é
žããã«ãã¢ã¯ãªã«é
žã€
ãœããã«ãã¢ã¯ãªã«é žããã·ã«ãã¢ã¯ãªã«é žãªã¯ãã«ãã¢ã¯ãªã«é žïŒâãšãã«ã
ãã·ã«ãã¢ã¯ãªã«é žã€ãœãªã¯ãã«ãã¢ã¯ãªã«é žãã·ã«ãã¢ã¯ãªã«é žã€ãœãã·ã«ã
ã¢ã¯ãªã«é žã©ãŠãªã«ãã¢ã¯ãªã«é žã¹ãã¢ãªã«ãã¡ã¿ã¯ãªã«é žã¡ãã«ãã¡ã¿ã¯ãªã«
é žãšãã«ãã¡ã¿ã¯ãªã«é žããã«ãã¡ã¿ã¯ãªã«é žã€ãœããã«ãã¡ã¿ã¯ãªã«é žâïŒãš
ãã«ããã·ã«ãã¡ã¿ã¯ãªã«é žã€ãœãªã¯ãã«ãã¡ã¿ã¯ãªã«é žãã·ã«ãã¡ã¿ã¯ãªã«é ž
ã€ãœãã·ã«ãã¡ã¿ã¯ãªã«é žã©ãŠãªã«ãã¡ã¿ã¯ãªã«é žã¹ãã¢ãªã«ãªã©ãäŸç€ºããã
ã
ãœããã«ãã¢ã¯ãªã«é žããã·ã«ãã¢ã¯ãªã«é žãªã¯ãã«ãã¢ã¯ãªã«é žïŒâãšãã«ã
ãã·ã«ãã¢ã¯ãªã«é žã€ãœãªã¯ãã«ãã¢ã¯ãªã«é žãã·ã«ãã¢ã¯ãªã«é žã€ãœãã·ã«ã
ã¢ã¯ãªã«é žã©ãŠãªã«ãã¢ã¯ãªã«é žã¹ãã¢ãªã«ãã¡ã¿ã¯ãªã«é žã¡ãã«ãã¡ã¿ã¯ãªã«
é žãšãã«ãã¡ã¿ã¯ãªã«é žããã«ãã¡ã¿ã¯ãªã«é žã€ãœããã«ãã¡ã¿ã¯ãªã«é žâïŒãš
ãã«ããã·ã«ãã¡ã¿ã¯ãªã«é žã€ãœãªã¯ãã«ãã¡ã¿ã¯ãªã«é žãã·ã«ãã¡ã¿ã¯ãªã«é ž
ã€ãœãã·ã«ãã¡ã¿ã¯ãªã«é žã©ãŠãªã«ãã¡ã¿ã¯ãªã«é žã¹ãã¢ãªã«ãªã©ãäŸç€ºããã
ã
äžèšå®èœæ§ã¢ãããŒã®äŸãšããŠã¯ãæ°Žé
žåºãæããã¢ãããŒãã«ã«ããã·ã«åº
ãæããã¢ãããŒãã¢ããåºãæããã¢ãããŒãã¢ããåºãæããã¢ãããŒãªã©
ãæãããããæ°Žé žåºãæããã¢ãããŒãšããŠã¯ãïŒâããããã·ãšãã«ïŒã¡ã¿
ïŒã¢ã¯ãªã¬ãŒããããããã·ãããã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããªã©ã®ããããã·ã¢
ã«ãã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããäŸç€ºããããã«ã«ããã·ã«åºãæããã¢ãããŒãš
ããŠã¯ãã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žãªã©ã®Î±âβäžé£œåã«ã«ãã³é žïŒãã¬ã€ã³é ž
ããã«ãªã©ã®ãã¬ã€ã³é žã¢ãã¢ã«ãã«ãšã¹ãã«ïŒãã¬ã€ã³é žïŒããã«é žïŒã¯ãã
ã³é žãªã©ãäŸç€ºããããç¡æ°Žãã¬ã€ã³é žããã¬ã€ã³é žãšåæ§ã®ïŒå ±ïŒéåæåã
äžãããã¢ããåºãæããã¢ãããŒãšããŠã¯ãã¢ã¯ãªã«ã¢ããããžã¡ãã«ã¢ã¯ãª
ã«ã¢ããããžãšãã«ã¢ã¯ãªã«ã¢ãããªã©ã®ã¢ã«ãã«ïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ããïŒã
ããã·ã¡ãã«ã¢ã¯ãªã«ã¢ããããšããã·ã¡ãã«ã¢ã¯ãªã«ã¢ãããªã©ã®ã¢ã«ãã«ãš
ãŒãã«ã¡ãããŒã«ïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ããããžã¢ã»ãã³ã¢ã¯ãªã«ã¢ãããªã©ãäŸ
瀺ããããã¢ããåºãæããã¢ãããŒãšããŠã¯ããžã¡ãã«ã¢ãããšãã«ã¢ã¯ãªã¬
ãŒããããã«ãããªãã³ãªã©ãäŸç€ºãããã
ãæããã¢ãããŒãã¢ããåºãæããã¢ãããŒãã¢ããåºãæããã¢ãããŒãªã©
ãæãããããæ°Žé žåºãæããã¢ãããŒãšããŠã¯ãïŒâããããã·ãšãã«ïŒã¡ã¿
ïŒã¢ã¯ãªã¬ãŒããããããã·ãããã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããªã©ã®ããããã·ã¢
ã«ãã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããäŸç€ºããããã«ã«ããã·ã«åºãæããã¢ãããŒãš
ããŠã¯ãã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žãªã©ã®Î±âβäžé£œåã«ã«ãã³é žïŒãã¬ã€ã³é ž
ããã«ãªã©ã®ãã¬ã€ã³é žã¢ãã¢ã«ãã«ãšã¹ãã«ïŒãã¬ã€ã³é žïŒããã«é žïŒã¯ãã
ã³é žãªã©ãäŸç€ºããããç¡æ°Žãã¬ã€ã³é žããã¬ã€ã³é žãšåæ§ã®ïŒå ±ïŒéåæåã
äžãããã¢ããåºãæããã¢ãããŒãšããŠã¯ãã¢ã¯ãªã«ã¢ããããžã¡ãã«ã¢ã¯ãª
ã«ã¢ããããžãšãã«ã¢ã¯ãªã«ã¢ãããªã©ã®ã¢ã«ãã«ïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ããïŒã
ããã·ã¡ãã«ã¢ã¯ãªã«ã¢ããããšããã·ã¡ãã«ã¢ã¯ãªã«ã¢ãããªã©ã®ã¢ã«ãã«ãš
ãŒãã«ã¡ãããŒã«ïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ããããžã¢ã»ãã³ã¢ã¯ãªã«ã¢ãããªã©ãäŸ
瀺ããããã¢ããåºãæããã¢ãããŒãšããŠã¯ããžã¡ãã«ã¢ãããšãã«ã¢ã¯ãªã¬
ãŒããããã«ãããªãã³ãªã©ãäŸç€ºãããã
äžèšä»¥å€ã®å
±éåç²ã¢ãããŒãšããŠã¯ãé
¢é
žããã«ãããã«ã¢ã«ã³ãŒã«ãã¹ã
ã¬ã³ãαâã¡ãã«ã¹ãã¬ã³ãå¡©åããã«ãã¢ã¯ãªããããªã«ããšãã¬ã³ãããã
ã¬ã³ããã¿ãžãšã³ãªã©ã䜿çšã§ãããç²çæ§åºå€äžã«ã¯ïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«
ãã«ãšã¹ãã«ãïŒå ±ïŒéåæåãšããŠïŒïŒééïŒ ä»¥äžå«æãããããšã奜ãŸãã
ã
ã¬ã³ãαâã¡ãã«ã¹ãã¬ã³ãå¡©åããã«ãã¢ã¯ãªããããªã«ããšãã¬ã³ãããã
ã¬ã³ããã¿ãžãšã³ãªã©ã䜿çšã§ãããç²çæ§åºå€äžã«ã¯ïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«
ãã«ãšã¹ãã«ãïŒå ±ïŒéåæåãšããŠïŒïŒééïŒ ä»¥äžå«æãããããšã奜ãŸãã
ã
ã¢ã¯ãªã«ç³»ç²çåºå€ã«ã¯ããã«å¿
èŠã«å¿ããŠå€å®èœæ§ã¢ãããŒãå ããããä»
ã®ã¢ãããŒæåãšå ±éåãããããã®å€å®èœæ§ã¢ãããŒã®æ·»å ã«ãããçæãã
éåäœéã«ãããããã«æ¶æ©ãçããããã«ããç²çåºå€ã®å éšåéåãå¢å€§ã
ãããã®ãã貌ä»ãããç®èã®æ§ç¶ãçºæ±éã«ã»ãšãã©ç¡é¢ä¿ã«è²Œä»å€å¥é¢æã®
ããããç³æ®ãçŸè±¡ãã»ãŒè§£æ¶ããããããããããã®å€å®èœæ§ã¢ãããŒã®æ·»å
ã¯è¬ç©ã®æŸåºæ§ãäœç®èåºæ¿æ§ã«ã¯äœãæªåœ±é¿ãäžããªãããã®ãããªå€å®èœæ§
ã¢ãããŒãšããŠã¯ãããšãã°ããžïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããããªïŒã¡ã¿ïŒã¢ã¯ãªã¬
ãŒããããã©ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããªã©ãããããããã«éå®ãããªããããå ·
äœçã«ã¯ããããµã¡ãã¬ã³ã°ãªã³ãŒã«ããªã¯ã¿ã¡ãã¬ã³ã°ãªã³ãŒã«ãªã©ã®ããªã¡
ãã¬ã³ã°ãªã³ãŒã«é¡ãšïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšãçµåãããŠåŸããããžïŒã¡ã¿ïŒã¢
ã¯ãªã¬ãŒãïŒããªãšãã¬ã³ã°ãªã³ãŒã«ãããªãããã¬ã³ã°ãªã³ãŒã«ãªã©ã®ããªã¢
ã«ãã¬ã³ã°ãªã³ãŒã«é¡ãšïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšãçµåãããŠåŸããããžïŒã¡ã¿ïŒ
ã¢ã¯ãªã¬ãŒãïŒããªã¡ãããŒã«ãããã³ããªïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããã°ãªã»ãªã³
ããªïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããªã©ã®ããªïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒãïŒããã³ãã³ã¿ãšãª
ã¹ãªããŒã«ããã©ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããªã©ã®ããã©ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããã
ãããããå€å®èœæ§ã¢ãããŒã¯ïŒçš®ä»¥äžã®çµã¿åããã§çšããŠããããå€å®èœæ§
ã¢ãããŒã¯ç²çåºå€ã®è£œé ã«äŸãããå šã¢ãããŒäžã«ïŒïŒïŒïŒïŒãïŒïŒïŒééïŒ
ã®å²åã§äœ¿çšããããå€å®èœæ§ã¢ãããŒã®äœ¿çšéãïŒïŒïŒïŒïŒééïŒ æªæºã§ãã
ãšãæ¶æ©ã«ããå éšåéååäžã®å¹æãå°ããããŸãïŒïŒïŒééïŒ ãè¶ ãããšé
åã«ããåŸãããç²çåºå€ãã²ã«åãèµ·ããæããè¬ç©ã®æ¡æ£ã»æŸåºã«ã圱é¿ã
çŸãããã
ã®ã¢ãããŒæåãšå ±éåãããããã®å€å®èœæ§ã¢ãããŒã®æ·»å ã«ãããçæãã
éåäœéã«ãããããã«æ¶æ©ãçããããã«ããç²çåºå€ã®å éšåéåãå¢å€§ã
ãããã®ãã貌ä»ãããç®èã®æ§ç¶ãçºæ±éã«ã»ãšãã©ç¡é¢ä¿ã«è²Œä»å€å¥é¢æã®
ããããç³æ®ãçŸè±¡ãã»ãŒè§£æ¶ããããããããããã®å€å®èœæ§ã¢ãããŒã®æ·»å
ã¯è¬ç©ã®æŸåºæ§ãäœç®èåºæ¿æ§ã«ã¯äœãæªåœ±é¿ãäžããªãããã®ãããªå€å®èœæ§
ã¢ãããŒãšããŠã¯ãããšãã°ããžïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããããªïŒã¡ã¿ïŒã¢ã¯ãªã¬
ãŒããããã©ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããªã©ãããããããã«éå®ãããªããããå ·
äœçã«ã¯ããããµã¡ãã¬ã³ã°ãªã³ãŒã«ããªã¯ã¿ã¡ãã¬ã³ã°ãªã³ãŒã«ãªã©ã®ããªã¡
ãã¬ã³ã°ãªã³ãŒã«é¡ãšïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšãçµåãããŠåŸããããžïŒã¡ã¿ïŒã¢
ã¯ãªã¬ãŒãïŒããªãšãã¬ã³ã°ãªã³ãŒã«ãããªãããã¬ã³ã°ãªã³ãŒã«ãªã©ã®ããªã¢
ã«ãã¬ã³ã°ãªã³ãŒã«é¡ãšïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšãçµåãããŠåŸããããžïŒã¡ã¿ïŒ
ã¢ã¯ãªã¬ãŒãïŒããªã¡ãããŒã«ãããã³ããªïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããã°ãªã»ãªã³
ããªïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããªã©ã®ããªïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒãïŒããã³ãã³ã¿ãšãª
ã¹ãªããŒã«ããã©ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããªã©ã®ããã©ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããã
ãããããå€å®èœæ§ã¢ãããŒã¯ïŒçš®ä»¥äžã®çµã¿åããã§çšããŠããããå€å®èœæ§
ã¢ãããŒã¯ç²çåºå€ã®è£œé ã«äŸãããå šã¢ãããŒäžã«ïŒïŒïŒïŒïŒãïŒïŒïŒééïŒ
ã®å²åã§äœ¿çšããããå€å®èœæ§ã¢ãããŒã®äœ¿çšéãïŒïŒïŒïŒïŒééïŒ æªæºã§ãã
ãšãæ¶æ©ã«ããå éšåéååäžã®å¹æãå°ããããŸãïŒïŒïŒééïŒ ãè¶ ãããšé
åã«ããåŸãããç²çåºå€ãã²ã«åãèµ·ããæããè¬ç©ã®æ¡æ£ã»æŸåºã«ã圱é¿ã
çŸãããã
ãŽã ç³»ç²çæ§åºå€ãšããŠã¯ã倩ç¶ãŽã ãã¹ãã¬ã³âã€ãœãã¬ã³âã¹ãã¬ã³ã»ã
ããã¯å ±éåäœïŒïŒ³ïŒ©ïŒ³ïŒãããªã€ãœãã¬ã³ãããªããã³ãããªã€ãœããã¬ã³ã
ãšãã¬ã³âé ¢é žããã«å ±éåäœãªã©ã®ãŽã 匟æ§äœïŒïŒïŒéééšã«ãç²çä» äžæš¹èïŒïŒãïŒïŒïŒéééšãããã³é©éã®è»åå€ãå®å®å€ãªã©ãæ·»å ããŠãªãã
ã®ã䜿çšãããã
ããã¯å ±éåäœïŒïŒ³ïŒ©ïŒ³ïŒãããªã€ãœãã¬ã³ãããªããã³ãããªã€ãœããã¬ã³ã
ãšãã¬ã³âé ¢é žããã«å ±éåäœãªã©ã®ãŽã 匟æ§äœïŒïŒïŒéééšã«ãç²çä» äžæš¹èïŒïŒãïŒïŒïŒéééšãããã³é©éã®è»åå€ãå®å®å€ãªã©ãæ·»å ããŠãªãã
ã®ã䜿çšãããã
ã·ãªã³ãŒã³ç³»ç²çæ§åºå€ãšããŠã¯ãããªãžã¡ãã«ã·ãããµã³ãªã©ãäž»æåãšã
ããã®ã䜿çšãããã
ããã®ã䜿çšãããã
äžèšç²çæ§åºå€äžã«ã¯ãããšãã°ããžã³ç³»æš¹èãããªãã«ãã³æš¹èãã¯ããã³
âã€ã³ãã³æš¹èãç³æ²¹ç³»æš¹èããã«ãã³âãã§ããŒã«æš¹èãªã©ã®ç²çæ§ä»äžå€ïŒ
液ç¶ããªããã³ãé±æ²¹ãã©ããªã³ã液ç¶ããªã€ãœãã¬ã³ã液ç¶ããªã¢ã¯ãªã¬ãŒã
ãªã©ã®å¯å¡å€ïŒå å¡«å€ïŒèåé²æ¢å€ãªã©ã®é åå€ãå¿ èŠã«å¿ããŠæ·»å ãããã
âã€ã³ãã³æš¹èãç³æ²¹ç³»æš¹èããã«ãã³âãã§ããŒã«æš¹èãªã©ã®ç²çæ§ä»äžå€ïŒ
液ç¶ããªããã³ãé±æ²¹ãã©ããªã³ã液ç¶ããªã€ãœãã¬ã³ã液ç¶ããªã¢ã¯ãªã¬ãŒã
ãªã©ã®å¯å¡å€ïŒå å¡«å€ïŒèåé²æ¢å€ãªã©ã®é åå€ãå¿ èŠã«å¿ããŠæ·»å ãããã
æ¬çºæã®çµç®åžå補å€ã«äœ¿çšãããç²çæ§åºå€ãšããŠç¹ã«å¥œãŸãããã®ã¯ãïŒ
ïœïŒäžèšïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšã¹ãã«ã¢ãããŒïŒïŒãïŒïŒïŒïŒééïŒ ãšãïŒïœïŒ
ãã¢ããªããŒã氎溶æ§ã§ãã£ãŠãïŒïœïŒã®ã¢ãããŒãšå ±éåå¯èœãªããã«ã¢ãã
ãŒïŒïŒïŒãïŒïŒééïŒ ãšãå«ãã é åç©ããåŸãããå ±éåäœã§ãããããã«ã¢
ãããŒïŒïœïŒãšããŠã¯ãããã«ãããªãã³ãç¡æ°Žãã¬ã€ã³é žãããã«ã¢ã«ã³ãŒã«
ãïŒã¡ã¿ïŒã¢ã¯ãªã«é žãªã©ãäŸç€ºãããããã®å ±éåäœã®äœ¿çšã«ãã£ãŠãç²çæ§
åºå€ãšåžåä¿é²å€ãšã®è¯å¥œãªçžæº¶æ§ãçºæ®ãããã貌ä»å±€ã®è²Œçæ§ãæãªãããª
ãã§ããã€ã補å€ã®é·æéå®å®æ§ãåäžãããããäžèšã¢ãããŒïŒïœïŒã¯è²Œä»å±€
ã®è²Œçæ§ãçºæ®ããã圹ç®ãæãããããã«ã¢ãããŒïŒïœïŒã¯ç²çæ§åºå€ãšåžå
ä¿é²å€ãšã®çžæº¶æ§ãçºæ®ããã圹ç®ãæããããããã£ãŠãã¢ãããŒïŒïœïŒã®å²
åãïŒïŒééïŒ æªæºã§ãããšç®èã«å¯Ÿãã貌ä»å±€ã®è²Œçæ§ãæªããªãããŸããã
ãã«ã¢ãããŒïŒïœïŒã®å²åãïŒïŒïŒééïŒ æªæºã§ãããšç²çæ§åºå€ãšåžåä¿é²å€
ãšã®çžæº¶æ§ãæªããªãã
ïœïŒäžèšïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšã¹ãã«ã¢ãããŒïŒïŒãïŒïŒïŒïŒééïŒ ãšãïŒïœïŒ
ãã¢ããªããŒã氎溶æ§ã§ãã£ãŠãïŒïœïŒã®ã¢ãããŒãšå ±éåå¯èœãªããã«ã¢ãã
ãŒïŒïŒïŒãïŒïŒééïŒ ãšãå«ãã é åç©ããåŸãããå ±éåäœã§ãããããã«ã¢
ãããŒïŒïœïŒãšããŠã¯ãããã«ãããªãã³ãç¡æ°Žãã¬ã€ã³é žãããã«ã¢ã«ã³ãŒã«
ãïŒã¡ã¿ïŒã¢ã¯ãªã«é žãªã©ãäŸç€ºãããããã®å ±éåäœã®äœ¿çšã«ãã£ãŠãç²çæ§
åºå€ãšåžåä¿é²å€ãšã®è¯å¥œãªçžæº¶æ§ãçºæ®ãããã貌ä»å±€ã®è²Œçæ§ãæãªãããª
ãã§ããã€ã補å€ã®é·æéå®å®æ§ãåäžãããããäžèšã¢ãããŒïŒïœïŒã¯è²Œä»å±€
ã®è²Œçæ§ãçºæ®ããã圹ç®ãæãããããã«ã¢ãããŒïŒïœïŒã¯ç²çæ§åºå€ãšåžå
ä¿é²å€ãšã®çžæº¶æ§ãçºæ®ããã圹ç®ãæããããããã£ãŠãã¢ãããŒïŒïœïŒã®å²
åãïŒïŒééïŒ æªæºã§ãããšç®èã«å¯Ÿãã貌ä»å±€ã®è²Œçæ§ãæªããªãããŸããã
ãã«ã¢ãããŒïŒïœïŒã®å²åãïŒïŒïŒééïŒ æªæºã§ãããšç²çæ§åºå€ãšåžåä¿é²å€
ãšã®çžæº¶æ§ãæªããªãã
iiiïŒ æ¬çºæã®çµç®åžå補å€ã«äœ¿çšãããè¬ç©ïŒçç掻æ§ç©è³ªïŒã¯ãçµç®çã«
çäœèãééããããã®ã§ããã°ãããç¹ã«éå®ãããªããè¬ç©ã®äŸãšããŠã¯ã
解ç±æ¶çé®çå€ãã¹ããã€ãç³»æççå€ãè¡ç®¡æ¡åŒµå€ãé«è¡å§ã»äžæŽèçšå€ãè¡
å§éäžå€ãé®å³å»ç°å€ãæè «çå€ãå±æ麻é å€ããã«ã¢ã³å€ãåæ¯ã»éŒ»ã¢ã¬ã«ã®
ãŒæ²»çå€ãæãã¹ã¿ãã³å€ãæåè¡å€ãé®çå€ãè³åŸªç°ã»ä»£è¬æ¹åå€ãæãã€ã»
æäžå®å€ããã¿ãã³ïŒ€è£œå€ãè¡ç³éäžå€ãæ朰çå€ãç¡ç å€ãæçç©è³ªãªã©ãæ
ããããã
çäœèãééããããã®ã§ããã°ãããç¹ã«éå®ãããªããè¬ç©ã®äŸãšããŠã¯ã
解ç±æ¶çé®çå€ãã¹ããã€ãç³»æççå€ãè¡ç®¡æ¡åŒµå€ãé«è¡å§ã»äžæŽèçšå€ãè¡
å§éäžå€ãé®å³å»ç°å€ãæè «çå€ãå±æ麻é å€ããã«ã¢ã³å€ãåæ¯ã»éŒ»ã¢ã¬ã«ã®
ãŒæ²»çå€ãæãã¹ã¿ãã³å€ãæåè¡å€ãé®çå€ãè³åŸªç°ã»ä»£è¬æ¹åå€ãæãã€ã»
æäžå®å€ããã¿ãã³ïŒ€è£œå€ãè¡ç³éäžå€ãæ朰çå€ãç¡ç å€ãæçç©è³ªãªã©ãæ
ããããã
解ç±æ¶çé®çå€ã®äŸãšããŠã¯ãã€ã³ãã¡ã¿ã·ã³ããµãªãã«é
žãã¢ã¹ããªã³ãã¢
ã»ãã¢ãããã§ã³ããžã¯ããã§ããã¯ãããªãŠã ãã€ããããã§ã³ãã¹ãªã³ãã
ã¯ãããããã»ã³ãã±ããããã§ã³ããã«ãã§ãã é žãã€ããã§ããã¯ããã§ã³
ããã§ã³ãã¢ã«ã¯ããã§ããã¯ããã§ãã«ãã¿ãŸã³ãã¡ãã§ãã é žããã³ãã¶ã
ã¯ããããã·ã«ã ããã«ã«ããããã§ã³ããã³ã¿ãŸã·ã³ãå¡©é žããã¬ãã«ãã£ã³
ãé ç³é žããã«ãã¡ããŒã«ãªã©ãæããããã
ã»ãã¢ãããã§ã³ããžã¯ããã§ããã¯ãããªãŠã ãã€ããããã§ã³ãã¹ãªã³ãã
ã¯ãããããã»ã³ãã±ããããã§ã³ããã«ãã§ãã é žãã€ããã§ããã¯ããã§ã³
ããã§ã³ãã¢ã«ã¯ããã§ããã¯ããã§ãã«ãã¿ãŸã³ãã¡ãã§ãã é žããã³ãã¶ã
ã¯ããããã·ã«ã ããã«ã«ããããã§ã³ããã³ã¿ãŸã·ã³ãå¡©é žããã¬ãã«ãã£ã³
ãé ç³é žããã«ãã¡ããŒã«ãªã©ãæããããã
ã¹ããã€ãç³»æççå€ã®äŸãšããŠã¯ããããã³ã«ããŸã³ããã¬ãããŸãã³ãã
ã«ãªã·ããã³ã¢ã»ãããããã«ãããã·ã³ã«ãããã¡ãã«ãã¬ãããŸãã³ãé ¢é ž
ãããã³ã«ããŸã³ãããªã¢ã ã·ããã³ã¢ã»ãããããããµã¡ã¿ãŸã³ãé ¢é žãã¿ã¡
ãµãŸã³ãåèé žãžãã«ã³ã«ããã³ãããããªã³é žã¯ããã¿ãŸãŒã«ããã«ãªã·ãã
ããªã©ãæããããã
ã«ãªã·ããã³ã¢ã»ãããããã«ãããã·ã³ã«ãããã¡ãã«ãã¬ãããŸãã³ãé ¢é ž
ãããã³ã«ããŸã³ãããªã¢ã ã·ããã³ã¢ã»ãããããããµã¡ã¿ãŸã³ãé ¢é žãã¿ã¡
ãµãŸã³ãåèé žãžãã«ã³ã«ããã³ãããããªã³é žã¯ããã¿ãŸãŒã«ããã«ãªã·ãã
ããªã©ãæããããã
è¡ç®¡æ¡åŒµå€ã®äŸãšããŠã¯ããžã«ãã¢ãŒã ããã©ããã«ãåç¡é
žãã³ã¿ãšãªã¹ãª
ããŒã«ããžããªãã¢ãŒã«ãç¡é žã€ãœãœã«ãããããã§ãžãã³ããããã°ãªã»ãªã³
ãªã©ãæããããã
ããŒã«ããžããªãã¢ãŒã«ãç¡é žã€ãœãœã«ãããããã§ãžãã³ããããã°ãªã»ãªã³
ãªã©ãæããããã
é«è¡å§ã»äžæŽèçšå€ãšããŠã¯ãããããããŒã«ãã¢ããããŒã«ããã³ãããŒã«
ãç¡«é žãããžã³ãã¢ãžããªã³ãå¡©é žã¢ã«ãã¬ãããŒã«ãé ç³é žã¡ãããããŒã«ã
ããããŒã«ããã¬ã€ã³é žãã¢ãŒãã«ããžãœãã©ãããªã©ãäŸç€ºãããã
ãç¡«é žãããžã³ãã¢ãžããªã³ãå¡©é žã¢ã«ãã¬ãããŒã«ãé ç³é žã¡ãããããŒã«ã
ããããŒã«ããã¬ã€ã³é žãã¢ãŒãã«ããžãœãã©ãããªã©ãäŸç€ºãããã
è¡å§éäžå€ã®äŸãšããŠã¯ãå¡©é
žã¯ãããžã³ãã«ããããªã«ãå¡©é
žãã©ãŸã·ã³ã
ç¡«é žãã³ããããŒã«ãé ¢é žã°ã¢ããã³ãºãå¡©é žã°ã¢ã³ãã¡ã·ã³ãå¡©é žãããŸã·ã³
ããã¬ã€ã³é žãšã©ãããªã«ãå¡©é žã¢ãããããŒã«ãå¡©é žããããããŒã«ãªã©ãæ
ããããã
ç¡«é žãã³ããããŒã«ãé ¢é žã°ã¢ããã³ãºãå¡©é žã°ã¢ã³ãã¡ã·ã³ãå¡©é žãããŸã·ã³
ããã¬ã€ã³é žãšã©ãããªã«ãå¡©é žã¢ãããããŒã«ãå¡©é žããããããŒã«ãªã©ãæ
ããããã
é®å³å»ç°å€ã®äŸãšããŠã¯ãå¡©é
žããã«ãããŒã«ãç¡«é
žãã«ãã¿ãªã³ãèåæ°ŽçŽ
é žãã§ããããŒã«ãå¡©é žããããããŒã«ãå¡©é žã¢ã³ããããœãŒã«ãå¡©é žãã«ãã
ããŒã«ãå¡©é žãããããŒã«ãå¡©é žã¯ã¬ã³ããããŒã«ãå¡©é žããªã¡ããããŒã«ãã
ãã«é žãã©ã«ã¢ãããŒã«ãªã©ãæããããã
é žãã§ããããŒã«ãå¡©é žããããããŒã«ãå¡©é žã¢ã³ããããœãŒã«ãå¡©é žãã«ãã
ããŒã«ãå¡©é žãããããŒã«ãå¡©é žã¯ã¬ã³ããããŒã«ãå¡©é žããªã¡ããããŒã«ãã
ãã«é žãã©ã«ã¢ãããŒã«ãªã©ãæããããã
æè
«çå€ãšããŠã¯ãïŒâãã«ãªããŠã©ã·ã«ãïŒâïŒïŒâããã©ãããããªã«ïŒ
âïŒâãã«ãªããŠã©ã·ã«ããã€ããã€ã·ã³ïŒ£ãªã©ãäŸç€ºãããã
âïŒâãã«ãªããŠã©ã·ã«ããã€ããã€ã·ã³ïŒ£ãªã©ãäŸç€ºãããã
å±æ麻é
å€ãšããŠã¯ããã³ãŸã«ã€ã³ãããã«ã€ã³ããªãã«ã€ã³ãããã©ã«ã€ã³
ãªã©ãäŸç€ºãããã
ãªã©ãäŸç€ºãããã
ãã«ã¢ã³å€ã®äŸãšããŠã¯ããšã¹ããã²ã³ããšã¹ãã©ãžãªãŒã«ããã¹ãã¹ããã³
ãããã²ã¹ããã³ãããã¹ã¿ã°ã©ã³ãžã³ãªã©ã®ã¹ããã€ããã«ã¢ã³é¡ããã€ã³ã¹
ãªã³ãªã©ã®ãããããã«ã¢ã³é¡ãªã©ãæããããã
ãããã²ã¹ããã³ãããã¹ã¿ã°ã©ã³ãžã³ãªã©ã®ã¹ããã€ããã«ã¢ã³é¡ããã€ã³ã¹
ãªã³ãªã©ã®ãããããã«ã¢ã³é¡ãªã©ãæããããã
åæ¯ã»éŒ»ã¢ã¬ã«ã®ãŒæ²»çå€ãšããŠã¯ãããã«é
žã±ãããã§ã³ãå¡©é
žã¢ãŒã©ã¹ã
ã³ãã¯ãã¢ã°ãªã¯é žãããªãŠã ãªã©ãäŸç€ºãããã
ã³ãã¯ãã¢ã°ãªã¯é žãããªãŠã ãªã©ãäŸç€ºãããã
æãã¹ã¿ãã³å€ãšããŠã¯å¡©é
žã·ã¯ãããã¿ãžã³ãå¡©é
žãžãã§ã³ããã©ãã³ãã
ã§ã³ãã³ã¶ãã³ãã¡ãã¿ãžã³ãªã©ãäŸç€ºãããã
ã§ã³ãã³ã¶ãã³ãã¡ãã¿ãžã³ãªã©ãäŸç€ºãããã
æåè¡å€ã®äŸãšããŠã¯ããããªã³ãªã©ãæããããã
é®çå€ãšããŠã¯ãã¹ã³ãã©ãã³ãã¯ããã«ãããŒã«ãªã©ãäŸç€ºãããã
è³åŸªç°ã»ä»£è¬æ¹åå€ã®äŸãšããŠã¯ããã³ãã»ãã³ãå¡©é
žãã«ããªãžã³ãå¡©é
žã
ã«ã«ãžãã³ãããã«é žãããã³ã«ãã³ãã¡ã·ã«é žãžããããšã«ãŽããã·ã³ãé ç³
é žã€ãã§ã³ãããžã«ãå¡©é žã€ãœã¯ã¹ããªã³ãªã©ãæããããã
ã«ã«ãžãã³ãããã«é žãããã³ã«ãã³ãã¡ã·ã«é žãžããããšã«ãŽããã·ã³ãé ç³
é žã€ãã§ã³ãããžã«ãå¡©é žã€ãœã¯ã¹ããªã³ãªã©ãæããããã
æãã€ã»æäžå®å€ã®äŸãšããŠã¯ãå¡©é
žãããããªã³ããšããŸã©ã ããžã¢ãŒãã
ãããããŒãã ãå¡©é žã¢ãããªãããªã³ãå¡©é žãã¢ã³ã»ãªã³ãªã©ãæããããã
ãããããŒãã ãå¡©é žã¢ãããªãããªã³ãå¡©é žãã¢ã³ã»ãªã³ãªã©ãæããããã
ãã¿ãã³ïŒ€è£œå€ã®äŸãšããŠã¯ãã¢ã«ãã¡ã«ã«ã·ããŒã«ããšã«ãŽã«ã«ã·ãã§ããŒ
ã«ãªã©ãæããããã
ã«ãªã©ãæããããã
è¡ç³éäžå€ã®äŸãšããŠã¯ãã°ãªãã³ã¯ã©ãããã°ãªã¯ã©ãžããªã©ãæãããã
ã
ã
æ朰çå€ã®äŸãšããŠã¯ããªã³ãŽé
žã¯ã¬ãããªãããã¡ã¢ããžã³ãèåã°ãªã³ã
ãããŠã ãªã©ãæããããã
ãããŠã ãªã©ãæããããã
ç¡ç å€ã®äŸãšããŠã¯ããã§ããã«ãã¿ãŒã«ãã¢ã¢ãã«ãã¿ãŒã«ãªã©ãæããã
ãã
ãã
æçç©è³ªãšããŠã¯ãããã©ãµã€ã¯ãªã³ãã¯ãã©ã ãã§ãã³ãŒã«ãªã©ãäŸç€ºãã
ãã
ãã
ãããã®è¬ç©ã®é
åéã¯ãè¬ç©ã®çš®é¡ãçµç®åžå補å€ã®äœ¿çšç®çãªã©ã«ããç°
ãªãããéåžžã¯è²Œä»å±€äžã«ïŒïŒïŒãïŒïŒééïŒ ã®ç¯å²ã§ããã
ãªãããéåžžã¯è²Œä»å±€äžã«ïŒïŒïŒãïŒïŒééïŒ ã®ç¯å²ã§ããã
ivïŒ æ¯æäœã¯ãæè»ã§ãããçµç®åžå補å€ã«èªå·±æ¯ææ§ãä»äžãããã€è²Œä»å±€
äžã®è¬ç©ã®æ®æ£ã移è¡ãé²æ¢ãã圹ç®ãæãããã®ã§ãã£ãŠãè¬ç©éééæ§ ã®ã·ãŒããªãããã£ã«ã ããããã®ã©ãããŒããç¹åžãªããäžç¹åžãªã©ã§æ§æã
ããŠãããæ¯æäœã®ææã®äŸãšããŠã¯ãé ¢é žã»ã«ããŒã¹ããšãã«ã»ã«ããŒã¹ãã
ãªãšãã¬ã³ãã¬ãã¿ã¬ãŒããé ¢é žããã«âå¡©åããã«å ±éåäœããã€ãã³ããšã
ã¬ã³âé ¢é žããã«å ±éåäœãå¯å¡åããªå¡©åããã«ãããªãŠã¬ã¿ã³ãããªãšãã¬
ã³ãããªå¡©åãããªãã³ãã¢ã«ãããŠã ãªã©ãæããããããããçŽ æã®ãã¡ã
ç®èé¢ã«å¯ŸããŠè¿œåŸæ§ãæããçŽ æã奜é©ã«çšãããããç¹ã«ãããªãšãã¬ã³ã
ã¬ãã¿ã¬ãŒããšãšãã¬ã³âé ¢é žããã«å ±éåäœãšã®ã©ãããŒããã£ã«ã ãªã©ã奜
ãŸãããæ¯æäœã®åã¿ã¯ïŒïŒïŒÎŒïœä»¥äžã奜ãŸããã¯ïŒãïŒïŒïŒÎŒïœã§ããã
äžã®è¬ç©ã®æ®æ£ã移è¡ãé²æ¢ãã圹ç®ãæãããã®ã§ãã£ãŠãè¬ç©éééæ§ ã®ã·ãŒããªãããã£ã«ã ããããã®ã©ãããŒããç¹åžãªããäžç¹åžãªã©ã§æ§æã
ããŠãããæ¯æäœã®ææã®äŸãšããŠã¯ãé ¢é žã»ã«ããŒã¹ããšãã«ã»ã«ããŒã¹ãã
ãªãšãã¬ã³ãã¬ãã¿ã¬ãŒããé ¢é žããã«âå¡©åããã«å ±éåäœããã€ãã³ããšã
ã¬ã³âé ¢é žããã«å ±éåäœãå¯å¡åããªå¡©åããã«ãããªãŠã¬ã¿ã³ãããªãšãã¬
ã³ãããªå¡©åãããªãã³ãã¢ã«ãããŠã ãªã©ãæããããããããçŽ æã®ãã¡ã
ç®èé¢ã«å¯ŸããŠè¿œåŸæ§ãæããçŽ æã奜é©ã«çšãããããç¹ã«ãããªãšãã¬ã³ã
ã¬ãã¿ã¬ãŒããšãšãã¬ã³âé ¢é žããã«å ±éåäœãšã®ã©ãããŒããã£ã«ã ãªã©ã奜
ãŸãããæ¯æäœã®åã¿ã¯ïŒïŒïŒÎŒïœä»¥äžã奜ãŸããã¯ïŒãïŒïŒïŒÎŒïœã§ããã
ïœïŒ æ¬çºæã«ããçµç®åžå貌ä»å€ã¯éåžžã¯ãã®è²Œä»é¢ã«å¥é¢çŽãæããŠããã
å¥é¢çŽãšããŠã¯ããªãšãã¬ã³ãã¬ãã¿ã¬ãŒãã®ãã£ã«ã ãã·ãªã³ã³åŠçããŠæã
ãã®ãããçšãããããããã¡ããå¥é¢çŽã¯ããã«éå®ãããªããå¥é¢çŽã®åã¿
ã¯ïŒïŒïŒÎŒïœä»¥äžã奜ãŸããã¯ïŒãïŒïŒÎŒïœã§ããã
å¥é¢çŽãšããŠã¯ããªãšãã¬ã³ãã¬ãã¿ã¬ãŒãã®ãã£ã«ã ãã·ãªã³ã³åŠçããŠæã
ãã®ãããçšãããããããã¡ããå¥é¢çŽã¯ããã«éå®ãããªããå¥é¢çŽã®åã¿
ã¯ïŒïŒïŒÎŒïœä»¥äžã奜ãŸããã¯ïŒãïŒïŒÎŒïœã§ããã
viïŒ æ¬çºæã«ããçµç®åžå補å€ã®è£œé æ³ãšããŠã¯ãéåžžã®ç²çããŒãã®è£œé æ¹
æ³ãé©çšã§ããããã®ä»£è¡šäŸã¯æº¶å€å¡å·¥æ³ã§ããããã以å€ã«ããšãã«ãžã§ã³å¡
å·¥æ³ããããã¡ã«ãæ³ãé»åç·æ¶æ©ã«ããæ¹æ³ãªã©ãçšãããããæ¬çºæã«ãã
çµç®åžå補å€ã溶å€å¡å·¥æ³ã§è£œé ããã«ã¯ãããšãã°ãç²çæ§åºå€ãè¬ç©ããã³
åžåä¿é²å€ãããã«å¿ èŠã«å¿ããŠé åå€ãé©åœãªæº¶åªã«æº¶è§£ãªããåæ£ãããåŸ
ããã溶液ãªããåæ£æ¶²ãæ¯æäœè¡šé¢ã«çŽæ¥å¡åžã»ä¹Ÿç¥ããåã¿ïŒïŒãïŒïŒïŒÎŒ
ïœã®è²Œä»å±€ã圢æããããŸãããã®æº¶æ¶²ãªããåæ£æ¶²ãä¿è·çšã®å¥é¢çŽäžã«å¡åž
ãã也ç¥åŸã«åŸããã貌ä»å±€ãæ¯æäœã«å¯çãããŠãããã
æ³ãé©çšã§ããããã®ä»£è¡šäŸã¯æº¶å€å¡å·¥æ³ã§ããããã以å€ã«ããšãã«ãžã§ã³å¡
å·¥æ³ããããã¡ã«ãæ³ãé»åç·æ¶æ©ã«ããæ¹æ³ãªã©ãçšãããããæ¬çºæã«ãã
çµç®åžå補å€ã溶å€å¡å·¥æ³ã§è£œé ããã«ã¯ãããšãã°ãç²çæ§åºå€ãè¬ç©ããã³
åžåä¿é²å€ãããã«å¿ èŠã«å¿ããŠé åå€ãé©åœãªæº¶åªã«æº¶è§£ãªããåæ£ãããåŸ
ããã溶液ãªããåæ£æ¶²ãæ¯æäœè¡šé¢ã«çŽæ¥å¡åžã»ä¹Ÿç¥ããåã¿ïŒïŒãïŒïŒïŒÎŒ
ïœã®è²Œä»å±€ã圢æããããŸãããã®æº¶æ¶²ãªããåæ£æ¶²ãä¿è·çšã®å¥é¢çŽäžã«å¡åž
ãã也ç¥åŸã«åŸããã貌ä»å±€ãæ¯æäœã«å¯çãããŠãããã
viiïŒ ããããŠåŸãããçµç®åžå補å€ã¯ãéåžžã¯è¬ç©ãç®èãçµãŠäœå
埪ç°åš
ç³»ãžæäžããç®çã§ãç®èè¡šé¢ã«çŽæ¥è²Œä»ããããããã«ãã®çµç®åžå補å€ã¯è¬
ç©ãç®èã®çŸæ£éšã®æ²»çãç®çãšããŠç®èã«è²Œä»ããŠããã¡ããããã
ç³»ãžæäžããç®çã§ãç®èè¡šé¢ã«çŽæ¥è²Œä»ããããããã«ãã®çµç®åžå補å€ã¯è¬
ç©ãç®èã®çŸæ£éšã®æ²»çãç®çãšããŠç®èã«è²Œä»ããŠããã¡ããããã
ïŒäœçšïŒ
æ¬çºæã«ããçµç®åžå補å€ã¯ãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³èªå°äœãš
ããªãšãã¬ã³ã°ãªã³ãŒã«ã®çµã¿åãããçšãããã®ã§ããã®ã§ãææã®è¬å¹ãçº
çŸãããã«å åãªéã®è¬ç©ãç®èãçµãŠåžåããããããšãã§ãããšå ±ã«ãåžå
ä¿é²å€ã«ããç®èåºæ¿ãäœæžããããã
ããªãšãã¬ã³ã°ãªã³ãŒã«ã®çµã¿åãããçšãããã®ã§ããã®ã§ãææã®è¬å¹ãçº
çŸãããã«å åãªéã®è¬ç©ãç®èãçµãŠåžåããããããšãã§ãããšå ±ã«ãåžå
ä¿é²å€ã«ããç®èåºæ¿ãäœæžããããã
ããªãªãã·ãšãã¬ã³èªå°äœãšããªãšãã¬ã³ã°ãªã³ãŒã«ãšãããªãåžåä¿é²å€ã®
ç®èã«å¯Ÿãã詳现ãªäœçšæ©åºã¯ã確ãããã®ã§ã¯ãªãããã€ãã®ããã«èããã
ãã
ç®èã«å¯Ÿãã詳现ãªäœçšæ©åºã¯ã確ãããã®ã§ã¯ãªãããã€ãã®ããã«èããã
ãã
ïŒïœïŒ æ¬åžåä¿é²å€ã®äœ¿çšã«ãããåäœé¢ç©ããã³åäœæéåœããã®è¬ç©ã®æŸ
åºéããã³ç®èå éšãžã®è¬ç©ã®ç§»è¡æ§ã極ããŠåäžãããããããã¯ãäžèšç©è³ª
ãç²çæ§åºå€ã®ç©æ§ãå€ãããšå ±ã«ãç®èå ã«æµžéããŠè§è³ªå±€ã®ç©çååŠçæ§è³ª
ãå€ããŠè§è³ªå±€ã®ããªã€ãŒæ©èœãæžéãããããã§ãããšèããããããã®çµæ
ãç²çæ§åºå€ãšç®èã®éã®è¬ç©ã®åé ä¿æ°ãå€åãããããã¯ãç®èäžã«ããã
è¬ç©ã®æ¡æ£é床ãé«ããããè¬ç©ã®æŸåºéãåäžãããšå ±ã«ãæèŠéã®è¬ç©ã容
æã«ç®èãééããŠäœå 埪ç°åšç³»ã«åžåãããã
åºéããã³ç®èå éšãžã®è¬ç©ã®ç§»è¡æ§ã極ããŠåäžãããããããã¯ãäžèšç©è³ª
ãç²çæ§åºå€ã®ç©æ§ãå€ãããšå ±ã«ãç®èå ã«æµžéããŠè§è³ªå±€ã®ç©çååŠçæ§è³ª
ãå€ããŠè§è³ªå±€ã®ããªã€ãŒæ©èœãæžéãããããã§ãããšèããããããã®çµæ
ãç²çæ§åºå€ãšç®èã®éã®è¬ç©ã®åé ä¿æ°ãå€åãããããã¯ãç®èäžã«ããã
è¬ç©ã®æ¡æ£é床ãé«ããããè¬ç©ã®æŸåºéãåäžãããšå ±ã«ãæèŠéã®è¬ç©ã容
æã«ç®èãééããŠäœå 埪ç°åšç³»ã«åžåãããã
ãã®ãããåŸæ¥ã®åžåä¿é²å€ã䜿çšããçµç®åžå補å€ãšæ¯èŒããŠãåäžé¢ç©ã®
åŸæ¥åãããæå¹æäžéã®å€§ããªçµç®åžå補å€ãåŸããããæèšããã°ãåŸæ¥å
ããå°ããé¢ç©ã®çµç®åžå補å€ã§åŸæ¥åãšåäžã®å¹æãåŸãããã
åŸæ¥åãããæå¹æäžéã®å€§ããªçµç®åžå補å€ãåŸããããæèšããã°ãåŸæ¥å
ããå°ããé¢ç©ã®çµç®åžå補å€ã§åŸæ¥åãšåäžã®å¹æãåŸãããã
ïŒïœïŒ ç®èåºæ¿ã®äœæžã«ã€ããŠã¯ãæ¬åžåä¿é²å€ã¯ãäžèšã®åŠããåªããçµç®
ééä¿é²å¹æã瀺ãç©è³ªã§ããã®ã§ãè¬ç©æäžã«å¿ èŠãªè²Œä»é¢ç©ãå°ãããŠãã¿
ãé·æ䜿çšã«éããŠç®èã®ãã¡ãŒãžãå°ãªãã
ééä¿é²å¹æã瀺ãç©è³ªã§ããã®ã§ãè¬ç©æäžã«å¿ èŠãªè²Œä»é¢ç©ãå°ãããŠãã¿
ãé·æ䜿çšã«éããŠç®èã®ãã¡ãŒãžãå°ãªãã
ãŸããäžèšã®ããã«å°ããé¢ç©ã®çµç®åžå補å€ã§å
åãªè¬å¹ãåŸãããããã
ç®èåºæ¿ã«ææãªäººã«ãããŠãçŽ æãçããããšãåé¿ããããããŸãã¯çŽ æã®
é¢ç©ãå¯åçã«çž®å°ããããããããŠãã®ããã«çµç®åžå補å€ãå°é¢ç©ã§ããã
ãã貌ä»æäœã容æã§ããäžã«ã貌ä»ã«ããéåæãå°ãªãã
ç®èåºæ¿ã«ææãªäººã«ãããŠãçŽ æãçããããšãåé¿ããããããŸãã¯çŽ æã®
é¢ç©ãå¯åçã«çž®å°ããããããããŠãã®ããã«çµç®åžå補å€ãå°é¢ç©ã§ããã
ãã貌ä»æäœã容æã§ããäžã«ã貌ä»ã«ããéåæãå°ãªãã
ïŒïœïŒ ããã«ãæ¬åžåä¿é²å€ã¯ãäžèšã®åŠããææã®è¬å¹ãçºçŸãããã®ã«å
åãªéã®è¬ç©ã容æã«çµç®çã«åžåããããããåŸæ¥ã®ããã«å€§éã®è¬ç©ã貌ä»
å±€ã«å«æãããå¿ èŠããªãã
åãªéã®è¬ç©ã容æã«çµç®çã«åžåããããããåŸæ¥ã®ããã«å€§éã®è¬ç©ã貌ä»
å±€ã«å«æãããå¿ èŠããªãã
ãŸããæ¬åžåä¿é²å€ã®äœ¿çšã«ãããæå¹è¡äžæ¿åºŠãé·æéã«ããã£ãŠç¶æãã
ããšãã§ããè¬ç©ã®ãã€ãªã¢ãã€ã©ããªãã£ãé«ããããã
ããšãã§ããè¬ç©ã®ãã€ãªã¢ãã€ã©ããªãã£ãé«ããããã
ãŸããæ¬åžåä¿é²å€ã¯ãè¬ç©ãå€æ§ãããããšããªããç²çæ§åºå€ãšã®çžæº¶æ§
ã«ãåªããã€è¬ç©ãšç²çæ§åºå€ãšã®çžæº¶æ§ã«å€åãäžããªããããçµç®åžå補å€
è¡šé¢ããè¬ç©ãæåºããããšããªãã
ã«ãåªããã€è¬ç©ãšç²çæ§åºå€ãšã®çžæº¶æ§ã«å€åãäžããªããããçµç®åžå補å€
è¡šé¢ããè¬ç©ãæåºããããšããªãã
ïŒå®æœäŸïŒ
ã€ãã«ãæ¬çºæãå®æœäŸã«åºã¥ããŠå
·äœçã«èª¬æããã
ïŒïœïŒ çµç®åžå補å€ã®è£œé å®æœäŸïŒ
ïœïŒ ã¢ã¯ãªã«ç³»ç²çæ§åºå€ã®èª¿è£œ
ã¢ã¯ãªã«é
žâïŒâãšãã«ããã·ã«ïŒïŒïŒïŒïŒïœãããã«ãããªãã³ïŒïŒïŒïŒïœ
ããã³ãããµã¡ãã¬ã³ã°ãªã³ãŒã«ãžã¡ã¿ã¯ãªã¬ãŒãïŒïŒïŒïŒïœïœïŒå šã¢ãããŒã«
察ããŠïŒïŒïŒïŒééïŒ ïŒãã»ãã©ãã«ãã©ã¹ã³ã«ä»èŸŒã¿ãããã«é ¢é žãšãã«ïŒïŒ
ïŒïŒïŒïœãå ããŠãã¢ãããŒæ¿åºŠãïŒïŒééïŒ ã«èª¿æŽããããã®æº¶æ¶²ãçªçŽ é°å²
æ°äžã«æž©åºŠïŒïŒâã«å ç±ããïŒïœã®éé žåã©ãŠãã€ã«ãã·ã¯ããããµã³ïŒïŒïŒïœ
ã«æº¶è§£ããŠãªãéåéå§å€æº¶æ¶²ããã³é ¢é žãšãã«ïŒïŒïŒïŒïŒïœãå°ããã€æ·»å ã
ãïŒïŒæéã«ãããéååå¿ãè¡ãªã£ããããããŠãåºåœ¢åæ¿åºŠïŒïŒééïŒ ãæ
ããã¢ã¯ãªã«ç³»ç²çæ§åºå€ã®é ¢é žãšãã«æº¶æ¶²ãåŸãã
ããã³ãããµã¡ãã¬ã³ã°ãªã³ãŒã«ãžã¡ã¿ã¯ãªã¬ãŒãïŒïŒïŒïŒïœïœïŒå šã¢ãããŒã«
察ããŠïŒïŒïŒïŒééïŒ ïŒãã»ãã©ãã«ãã©ã¹ã³ã«ä»èŸŒã¿ãããã«é ¢é žãšãã«ïŒïŒ
ïŒïŒïŒïœãå ããŠãã¢ãããŒæ¿åºŠãïŒïŒééïŒ ã«èª¿æŽããããã®æº¶æ¶²ãçªçŽ é°å²
æ°äžã«æž©åºŠïŒïŒâã«å ç±ããïŒïœã®éé žåã©ãŠãã€ã«ãã·ã¯ããããµã³ïŒïŒïŒïœ
ã«æº¶è§£ããŠãªãéåéå§å€æº¶æ¶²ããã³é ¢é žãšãã«ïŒïŒïŒïŒïŒïœãå°ããã€æ·»å ã
ãïŒïŒæéã«ãããéååå¿ãè¡ãªã£ããããããŠãåºåœ¢åæ¿åºŠïŒïŒééïŒ ãæ
ããã¢ã¯ãªã«ç³»ç²çæ§åºå€ã®é ¢é žãšãã«æº¶æ¶²ãåŸãã
iiïŒ è²Œä»çšé
åç©å«æ液ã®èª¿è£œ
åŸãããç²çæ§åºå€æº¶æ¶²ã«ãè¬ç©ãšããŠç¡é
žã€ãœãœã«ãããããã³åžåä¿é²å€
ãšããŠããªãªãã·ãšãã¬ã³ïŒïŒïŒã©ãŠãªã«ãšãŒãã«ãªã³é žãããªãŠã ãšããªãšã
ã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒïŒãå«ãé ¢é žãšãã«æº¶æ¶²ããåºåœ¢åïŒç²çæ§åºå€
ãè¬ç©ããã³åžåä¿é²å€ã®ééåïŒæ¿åºŠãïŒïŒééïŒ ãšãªãããã«ããã€ãç¡é ž
ã€ãœãœã«ãããããªãªãã·ãšãã¬ã³ïŒïŒïŒã©ãŠãªã«ãšãŒãã«ãªã³é žãããªãŠã ã
ãã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã®åºåœ¢åäžæ¿åºŠãããããïŒïŒïŒïŒééïŒ ãïŒéé
ïŒ ããã³ïŒïŒééïŒ ãšãªãããã«å ããŠãæ¶²å šäœããã£ãŸã«ããŒã«ãŠåäžã«æ··å
ãããããããŠã貌ä»çšé åç©ãå«æããé ¢é žãšãã«æº¶æ¶²ã調補ããã
ãšããŠããªãªãã·ãšãã¬ã³ïŒïŒïŒã©ãŠãªã«ãšãŒãã«ãªã³é žãããªãŠã ãšããªãšã
ã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒïŒãå«ãé ¢é žãšãã«æº¶æ¶²ããåºåœ¢åïŒç²çæ§åºå€
ãè¬ç©ããã³åžåä¿é²å€ã®ééåïŒæ¿åºŠãïŒïŒééïŒ ãšãªãããã«ããã€ãç¡é ž
ã€ãœãœã«ãããããªãªãã·ãšãã¬ã³ïŒïŒïŒã©ãŠãªã«ãšãŒãã«ãªã³é žãããªãŠã ã
ãã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã®åºåœ¢åäžæ¿åºŠãããããïŒïŒïŒïŒééïŒ ãïŒéé
ïŒ ããã³ïŒïŒééïŒ ãšãªãããã«å ããŠãæ¶²å šäœããã£ãŸã«ããŒã«ãŠåäžã«æ··å
ãããããããŠã貌ä»çšé åç©ãå«æããé ¢é žãšãã«æº¶æ¶²ã調補ããã
iiiïŒ çµç®åžå補å€ã®èª¿è£œ
åãïŒïŒÎŒïœã®ããªãšãã¬ã³ãã¬ãã¿ã¬ãŒãïŒïŒ°ïŒ¥ïŒŽïŒã®ãã£ã«ã ãã·ãªã³ã³
åŠçããŠãªãå¥é¢çŽäžã«ãå·¥çšiiïŒã®èª¿è£œæ¶²ãå¡åžããåŸãïŒïŒâã§ïŒïŒåé也
ç¥ããåãïŒïŒÎŒïœã®è²Œä»å±€ã圢æãããã€ãã§ããšãšãã¬ã³âé ¢é žãã
ã«ã®å ±éåäœïŒïŒ°ïŒ¥ïŒŽâïŒãã©ãããŒãããŠãªãåãïŒïŒÎŒïœã®æ¯æäœã
貌ä»å±€ã«å¯çããããããããŠãçµç®åžå補å€ã調補ãããå®æœäŸïŒãïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³ïŒïŒïŒã©
ãŠãªã«ãšãŒãã«ãªã³é žãããªãŠã ãšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒïŒã
ãããããè¡šïŒã«ç€ºãåºåœ¢åäžæ¿åºŠã®é åçµæã§äœ¿çšãããã®ä»ã®æäœãå®æœäŸ
ïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããæ¯èŒäŸïŒãïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³ïŒïŒïŒã©
ãŠãªã«ãšãŒãã«ãªã³é žãããªãŠã ãšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒïŒã®
ãã¡ã®ããããäžæ¹ããè¡šïŒã«ç€ºãåºåœ¢åäžæ¿åºŠã®é åçµæã§äœ¿çšãããããŸã
ã¯äž¡è ã®ã©ã¡ããã䜿çšããããã®ä»ã®æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åž
å補å€ã調補ããã
åŠçããŠãªãå¥é¢çŽäžã«ãå·¥çšiiïŒã®èª¿è£œæ¶²ãå¡åžããåŸãïŒïŒâã§ïŒïŒåé也
ç¥ããåãïŒïŒÎŒïœã®è²Œä»å±€ã圢æãããã€ãã§ããšãšãã¬ã³âé ¢é žãã
ã«ã®å ±éåäœïŒïŒ°ïŒ¥ïŒŽâïŒãã©ãããŒãããŠãªãåãïŒïŒÎŒïœã®æ¯æäœã
貌ä»å±€ã«å¯çããããããããŠãçµç®åžå補å€ã調補ãããå®æœäŸïŒãïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³ïŒïŒïŒã©
ãŠãªã«ãšãŒãã«ãªã³é žãããªãŠã ãšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒïŒã
ãããããè¡šïŒã«ç€ºãåºåœ¢åäžæ¿åºŠã®é åçµæã§äœ¿çšãããã®ä»ã®æäœãå®æœäŸ
ïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããæ¯èŒäŸïŒãïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³ïŒïŒïŒã©
ãŠãªã«ãšãŒãã«ãªã³é žãããªãŠã ãšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒïŒã®
ãã¡ã®ããããäžæ¹ããè¡šïŒã«ç€ºãåºåœ¢åäžæ¿åºŠã®é åçµæã§äœ¿çšãããããŸã
ã¯äž¡è ã®ã©ã¡ããã䜿çšããããã®ä»ã®æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åž
å補å€ã調補ããã
å®æœäŸïŒ
ïœïŒ ã¢ã¯ãªã«ç³»ç²çæ§åºå€ã®èª¿è£œ
ã¢ã¯ãªã«é
žâïŒâãšãã«ããã·ã«ïŒïŒïœãã¡ã¿ã¯ãªã«é
žâïŒâãšãã«ããã·ã«
ïŒïŒïŒïœãã¡ã¿ã¯ãªã«é žããã·ã«ïŒïŒïœããã³ã¢ã¯ãªã«é žïŒïŒïœãã»ãã©ãã«ã
ã©ã¹ã³ã«ä»èŸŒã¿ãããã«é ¢é žãšãã«ïŒïŒïŒïœãå ããŠãã¢ãããŒæ¿åºŠãïŒïŒéé
ïŒ ã«èª¿æŽããããã®æº¶æ¶²ãçªçŽ é°å²æ°äžã«æž©åºŠïŒïŒâã«å ç±ããïŒïœã®éé žåã©
ãŠãã€ã«ãã·ã¯ããããµã³ïŒïŒïŒïœã«æº¶è§£ããŠãªãéåéå§å€æº¶æ¶²ããã³é ¢é žãš
ãã«ïŒïŒïŒïœãå°ããã€æ·»å ããïŒïŒæéã«ãããéååå¿ãè¡ãªã£ããããã
ãŠãåºåœ¢åæ¿åºŠïŒïŒééïŒ ãæããã¢ã¯ãªã«ç³»ç²çæ§åºå€ã®é ¢é žãšãã«æº¶æ¶²ãåŸ
ãã
ïŒïŒïŒïœãã¡ã¿ã¯ãªã«é žããã·ã«ïŒïŒïœããã³ã¢ã¯ãªã«é žïŒïŒïœãã»ãã©ãã«ã
ã©ã¹ã³ã«ä»èŸŒã¿ãããã«é ¢é žãšãã«ïŒïŒïŒïœãå ããŠãã¢ãããŒæ¿åºŠãïŒïŒéé
ïŒ ã«èª¿æŽããããã®æº¶æ¶²ãçªçŽ é°å²æ°äžã«æž©åºŠïŒïŒâã«å ç±ããïŒïœã®éé žåã©
ãŠãã€ã«ãã·ã¯ããããµã³ïŒïŒïŒïœã«æº¶è§£ããŠãªãéåéå§å€æº¶æ¶²ããã³é ¢é žãš
ãã«ïŒïŒïŒïœãå°ããã€æ·»å ããïŒïŒæéã«ãããéååå¿ãè¡ãªã£ããããã
ãŠãåºåœ¢åæ¿åºŠïŒïŒééïŒ ãæããã¢ã¯ãªã«ç³»ç²çæ§åºå€ã®é ¢é žãšãã«æº¶æ¶²ãåŸ
ãã
iiïŒ è²Œä»çšé
åç©å«æ液ã®èª¿è£œ
åŸãããç²çæ§åºå€æº¶æ¶²ã«ãè¬ç©ãšããŠã€ã³ãã¡ã¿ã·ã³ãããã³åžåä¿é²å€ãš
ããŠããªãªãã·ãšãã¬ã³ãœã«ãã¿ã³ã¢ãã©ãŠã¬ãŒããšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒ
ååéïŒïŒïŒïŒãå«ãé ¢é žãšãã«æº¶æ¶²ããåºåœ¢åïŒç²çæ§åºå€ãè¬ç©ããã³åžå
ä¿é²å€ã®ééåïŒæ¿åºŠãïŒïŒééïŒ ãšãªãããã«ããã€ãã€ã³ãã¡ã¿ã·ã³ãããª
ãªãã·ãšãã¬ã³ãœã«ãã¿ã³ã¢ãã©ãŠã¬ãŒãããã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã®åºåœ¢
åäžæ¿åºŠãããããïŒééïŒ ãïŒééïŒ ããã³ïŒïŒééïŒ ãšãªãããã«å ããŠã
æ¶²å šäœããã£ãŸã«ããŒã«ãŠåäžã«æ··åãããããããŠã貌ä»çšé åç©ãå«æãã
é ¢é žãšãã«æº¶æ¶²ã調補ããã
ããŠããªãªãã·ãšãã¬ã³ãœã«ãã¿ã³ã¢ãã©ãŠã¬ãŒããšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒ
ååéïŒïŒïŒïŒãå«ãé ¢é žãšãã«æº¶æ¶²ããåºåœ¢åïŒç²çæ§åºå€ãè¬ç©ããã³åžå
ä¿é²å€ã®ééåïŒæ¿åºŠãïŒïŒééïŒ ãšãªãããã«ããã€ãã€ã³ãã¡ã¿ã·ã³ãããª
ãªãã·ãšãã¬ã³ãœã«ãã¿ã³ã¢ãã©ãŠã¬ãŒãããã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã®åºåœ¢
åäžæ¿åºŠãããããïŒééïŒ ãïŒééïŒ ããã³ïŒïŒééïŒ ãšãªãããã«å ããŠã
æ¶²å šäœããã£ãŸã«ããŒã«ãŠåäžã«æ··åãããããããŠã貌ä»çšé åç©ãå«æãã
é ¢é žãšãã«æº¶æ¶²ã調補ããã
iiiïŒ çµç®åžå補å€ã®èª¿è£œ
å®æœäŸïŒã®å·¥çšiiiïŒãšåãæäœã«ãããã·ãªã³ã³åŠçãããªãå¥é¢çŽ
äžã«è²Œä»å±€ã圢æãããã®å±€ã«ïŒ°ïŒ¥ïŒŽâãããªãæ¯æäœãå¯çãããŠãçµ
ç®åžå補å€ã調補ãããæ¯èŒäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšããããã®ä»ã®
æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããå®æœäŸïŒ å®æœäŸïŒã®å·¥çšïœïŒã«ãããŠãã¢ã¯ãªã«é žã䜿çšãããé ¢é žãšãã«ïŒïŒïŒïœã®
代ããã«ïŒïŒïŒïœãé ¢é žãšãã«ïŒïŒïŒïœã®ä»£ããã«ïŒïŒïŒïœãçšãããŸãå® æœäŸïŒã®å·¥çšiiïŒã«ãããŠããªãšãã¬ã³ã°ãªã³ãŒã«ãåºåœ¢åäžæ¿åºŠïŒïŒ ã®é åçµ
æã§äœ¿çšãããã®ä»ã®æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãã
ãæ¯èŒäŸïŒ å®æœäŸïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšããããã®ä»ã®æäœãå®æœ
äŸïŒãšåæ§ã«è¡ãªã£ãŠãçµç®åžå補å€ã調補ãããå®æœäŸïŒ ïœïŒ ãŽã ç³»ç²çæ§åºå€ã®èª¿è£œ ãŽã 匟æ§äœãšããŠã¹ãã¬ã³âã€ãœãã¬ã³âã¹ãã¬ã³ã»ãããã¯å ±éåäœïŒã·ã§
ã«ååŠç€Ÿè£œãã«ãªãã¬ãã¯ã¹ïŒŽïŒ²ïŒïŒïŒïŒïŒïŒïŒïŒéééšã«å¯Ÿããç²çä»äžå€ãš
ããŠèç°ææ°ŽçŽ æ·»å ç³æ²¹æš¹èïŒèå·ååŠç€Ÿè£œãã¢ã«ã³ãŒã³âïŒïŒïŒïŒïŒïŒéé
éšãè»åå€ãšããŠããªããã³ïŒæ¥ç³ååŠç€Ÿè£œãâïŒïŒïŒïŒïŒïŒéééšãã·ã¯
ããããµã³ïŒïŒïŒïŒïŒïŒéééšã«æº¶è§£ãããŠãåºåœ¢åæ¿åºŠïŒïŒïŒïŒïŒééïŒ ãæ
ãããŽã ç³»ç²çæ§åºå€ã®ã·ã¯ããããµã³æº¶æ¶²ãåŸãã
äžã«è²Œä»å±€ã圢æãããã®å±€ã«ïŒ°ïŒ¥ïŒŽâãããªãæ¯æäœãå¯çãããŠãçµ
ç®åžå補å€ã調補ãããæ¯èŒäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšããããã®ä»ã®
æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããå®æœäŸïŒ å®æœäŸïŒã®å·¥çšïœïŒã«ãããŠãã¢ã¯ãªã«é žã䜿çšãããé ¢é žãšãã«ïŒïŒïŒïœã®
代ããã«ïŒïŒïŒïœãé ¢é žãšãã«ïŒïŒïŒïœã®ä»£ããã«ïŒïŒïŒïœãçšãããŸãå® æœäŸïŒã®å·¥çšiiïŒã«ãããŠããªãšãã¬ã³ã°ãªã³ãŒã«ãåºåœ¢åäžæ¿åºŠïŒïŒ ã®é åçµ
æã§äœ¿çšãããã®ä»ã®æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãã
ãæ¯èŒäŸïŒ å®æœäŸïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšããããã®ä»ã®æäœãå®æœ
äŸïŒãšåæ§ã«è¡ãªã£ãŠãçµç®åžå補å€ã調補ãããå®æœäŸïŒ ïœïŒ ãŽã ç³»ç²çæ§åºå€ã®èª¿è£œ ãŽã 匟æ§äœãšããŠã¹ãã¬ã³âã€ãœãã¬ã³âã¹ãã¬ã³ã»ãããã¯å ±éåäœïŒã·ã§
ã«ååŠç€Ÿè£œãã«ãªãã¬ãã¯ã¹ïŒŽïŒ²ïŒïŒïŒïŒïŒïŒïŒïŒéééšã«å¯Ÿããç²çä»äžå€ãš
ããŠèç°ææ°ŽçŽ æ·»å ç³æ²¹æš¹èïŒèå·ååŠç€Ÿè£œãã¢ã«ã³ãŒã³âïŒïŒïŒïŒïŒïŒéé
éšãè»åå€ãšããŠããªããã³ïŒæ¥ç³ååŠç€Ÿè£œãâïŒïŒïŒïŒïŒïŒéééšãã·ã¯
ããããµã³ïŒïŒïŒïŒïŒïŒéééšã«æº¶è§£ãããŠãåºåœ¢åæ¿åºŠïŒïŒïŒïŒïŒééïŒ ãæ
ãããŽã ç³»ç²çæ§åºå€ã®ã·ã¯ããããµã³æº¶æ¶²ãåŸãã
iiïŒ è²Œä»çšé
åç©å«æ液ã®èª¿è£œ
åŸãããç²çæ§åºå€æº¶æ¶²ã«ãè¬ç©ãšããŠãããã·ã«ã ãããã³åžåä¿é²å€ãšã
ãŠããªãªãã·ãšãã¬ã³ããªã¹ãã«ãšãŒãã«ãšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒ
ïŒïŒïŒãå«ãããã©ããããã©ã³æº¶æ¶²ããåºåœ¢åïŒç²çæ§åºå€ãè¬ç©ããã³åžå
ä¿é²å€ã®ééåïŒæ¿åºŠãïŒïŒééïŒ ãšãªãããã«ããã€ããããã·ã«ã ãããªãª
ãã·ãšãã¬ã³ããªã¹ãã«ãšãŒãã«ããã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã®åºåœ¢åäžæ¿åºŠ
ãããããïŒééïŒ ãïŒééïŒ ããã³ïŒééïŒ ãšãªãããã«å ããŠãæ¶²å šäœãã
ã£ãŸã«ããŒã«ãŠåäžã«æ··åãããããããŠã貌ä»çšé åç©ãå«æããã·ã¯ããã
ãµã³ãããã©ããããã©ã³æ··å溶液ã調補ããã
ãŠããªãªãã·ãšãã¬ã³ããªã¹ãã«ãšãŒãã«ãšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒ
ïŒïŒïŒãå«ãããã©ããããã©ã³æº¶æ¶²ããåºåœ¢åïŒç²çæ§åºå€ãè¬ç©ããã³åžå
ä¿é²å€ã®ééåïŒæ¿åºŠãïŒïŒééïŒ ãšãªãããã«ããã€ããããã·ã«ã ãããªãª
ãã·ãšãã¬ã³ããªã¹ãã«ãšãŒãã«ããã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã®åºåœ¢åäžæ¿åºŠ
ãããããïŒééïŒ ãïŒééïŒ ããã³ïŒééïŒ ãšãªãããã«å ããŠãæ¶²å šäœãã
ã£ãŸã«ããŒã«ãŠåäžã«æ··åãããããããŠã貌ä»çšé åç©ãå«æããã·ã¯ããã
ãµã³ãããã©ããããã©ã³æ··å溶液ã調補ããã
iiiïŒ çµç®åžå補å€ã®èª¿è£œ
å®æœäŸïŒã®å·¥çšiiiïŒãšåãæäœã«ãããã·ãªã³ã³åŠçãããªãå¥é¢çŽ
äžã«è²Œä»å±€ã圢æãããã®å±€ã«ïŒ°ïŒ¥ïŒŽâãããªãæ¯æäœãå¯çãããŠãçµ
ç®åžå補å€ã調補ãããæ¯èŒäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšãããããªãª ãã·ãšãã¬ã³ããªã¹ãã«ãšãŒãã«ãåºåœ¢åäžæ¿åºŠïŒïŒééïŒ ã®é åçµæã§äœ¿çšã
ããã®ä»ã®æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããå®æœäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãåºåœ¢åæ¿åºŠïŒïŒééïŒ ã®ç²çæ§åºå€æº¶æ¶²ã«ãè¬
ç©ãšããŠå¹³åç²ååŸïŒïŒÎŒïœã®ãšã¹ãã©ãžãªãŒã«ã®çµæ¶ãããã³åžåä¿é²å€ãšã
ãŠããªãªãã·ãšãã¬ã³ã¢ãã©ãŠã¬ãŒããšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒ
ïŒïŒãå«ãé ¢é žãšãã«æº¶æ¶²ããåºåœ¢åïŒç²çæ§åºå€ãè¬ç©ããã³åžåä¿é²å€ã®é
éåïŒæ¿åºŠãïŒïŒééïŒ ãšãªãããã«ããã€ããšã¹ãã©ãžãªãŒã«ãããªãªãã·ãš
ãã¬ã³ã¢ãã©ãŠã¬ãŒãããã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã®åºåœ¢åäžæ¿åºŠããããã
ïŒïŒééïŒ ãïŒééïŒ ããã³ïŒïŒééïŒ ãšãªãããã«å ãããã®ä»ã®æäœãå®æœ
äŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããæ¯èŒäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšããããã®ä»ã®
æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããå®æœäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãåºåœ¢åæ¿åºŠïŒïŒééïŒ ã®ç²çæ§åºå€æº¶æ¶²ã«ãè¬
ç©ãšããŠããã§ãžãã³ãããã³åžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³ãªã¬ã€ã«ã¢
ãã³ãšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒïŒãå«ãé ¢é žãšãã«æº¶æ¶²ããåºåœ¢
åïŒç²çæ§åºå€ãè¬ç©ããã³åžåä¿é²å€ã®ééåïŒæ¿åºŠãïŒïŒééïŒ ãšãªããã
ã«ããã€ãããã§ãžãã³ãããªãªãã·ãšãã¬ã³ãªã¬ã€ã«ã¢ãã³ããã³ããªãšãã¬
ã³ã°ãªã³ãŒã«ã®åºåœ¢åäžæ¿åºŠãããããïŒïŒééïŒ ãïŒïŒééïŒ ããã³ïŒééïŒ
ãšãªãããã«å ãããã®ä»ã®æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調
補ãããæ¯èŒäŸïŒïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšããããã®ä»ã®
æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ããã
äžã«è²Œä»å±€ã圢æãããã®å±€ã«ïŒ°ïŒ¥ïŒŽâãããªãæ¯æäœãå¯çãããŠãçµ
ç®åžå補å€ã調補ãããæ¯èŒäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšãããããªãª ãã·ãšãã¬ã³ããªã¹ãã«ãšãŒãã«ãåºåœ¢åäžæ¿åºŠïŒïŒééïŒ ã®é åçµæã§äœ¿çšã
ããã®ä»ã®æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããå®æœäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãåºåœ¢åæ¿åºŠïŒïŒééïŒ ã®ç²çæ§åºå€æº¶æ¶²ã«ãè¬
ç©ãšããŠå¹³åç²ååŸïŒïŒÎŒïœã®ãšã¹ãã©ãžãªãŒã«ã®çµæ¶ãããã³åžåä¿é²å€ãšã
ãŠããªãªãã·ãšãã¬ã³ã¢ãã©ãŠã¬ãŒããšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒ
ïŒïŒãå«ãé ¢é žãšãã«æº¶æ¶²ããåºåœ¢åïŒç²çæ§åºå€ãè¬ç©ããã³åžåä¿é²å€ã®é
éåïŒæ¿åºŠãïŒïŒééïŒ ãšãªãããã«ããã€ããšã¹ãã©ãžãªãŒã«ãããªãªãã·ãš
ãã¬ã³ã¢ãã©ãŠã¬ãŒãããã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã®åºåœ¢åäžæ¿åºŠããããã
ïŒïŒééïŒ ãïŒééïŒ ããã³ïŒïŒééïŒ ãšãªãããã«å ãããã®ä»ã®æäœãå®æœ
äŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããæ¯èŒäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšããããã®ä»ã®
æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ãããå®æœäŸïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãåºåœ¢åæ¿åºŠïŒïŒééïŒ ã®ç²çæ§åºå€æº¶æ¶²ã«ãè¬
ç©ãšããŠããã§ãžãã³ãããã³åžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³ãªã¬ã€ã«ã¢
ãã³ãšããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååéïŒïŒïŒïŒãå«ãé ¢é žãšãã«æº¶æ¶²ããåºåœ¢
åïŒç²çæ§åºå€ãè¬ç©ããã³åžåä¿é²å€ã®ééåïŒæ¿åºŠãïŒïŒééïŒ ãšãªããã
ã«ããã€ãããã§ãžãã³ãããªãªãã·ãšãã¬ã³ãªã¬ã€ã«ã¢ãã³ããã³ããªãšãã¬
ã³ã°ãªã³ãŒã«ã®åºåœ¢åäžæ¿åºŠãããããïŒïŒééïŒ ãïŒïŒééïŒ ããã³ïŒééïŒ
ãšãªãããã«å ãããã®ä»ã®æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調
補ãããæ¯èŒäŸïŒïŒ å®æœäŸïŒã®å·¥çšiiïŒã«ãããŠãããªãšãã¬ã³ã°ãªã³ãŒã«ã䜿çšããããã®ä»ã®
æäœãå®æœäŸïŒãšåæ§ã«è¡ãªã£ãŠçµç®åžå補å€ã調補ããã
ïŒïœïŒ çµç®åžå補å€ã®æ§èœè©äŸ¡ïœïŒ ãŠãµã®ç®è移è¡æ§è©Šéš
å®æœäŸïŒãïŒãïŒãïŒãïŒããã³æ¯èŒäŸïŒãïŒãïŒãïŒãïŒã®çµç®åžå補å€
ã«ã€ããŠãè©ŠéšïŒã«ç€ºãææ³ã«ãããŠãµã®ã®ç®èã«å¯Ÿããè¬ç©ã®ç§»è¡æ§è©Šéšãè¡
ãªã£ãã
ãªã£ãã
è©ŠéšïŒ
ïŒçŸœã®ãŠãµã®ïŒãã¥ãŒãžãŒã©ã³ãã»ãã¯ã€ãçš®ïŒã®è±æ¯ããèéšããã³è
¹åŽéš
ã«çµç®åžå補å€ã®è©ŠéšçïŒé¢ç©ïŒïŒcm2ïŒã貌ä»ããïŒïŒæéåŸãããå¥é¢ããŠ
ååãããç¹°ãè¿ãåæ°ã¯å補å€æ¯ã«ïŒåãšãããè¬ç©ãç¡é žã€ãœãœã«ããã§ã
ãå Žåã¯ããããã®è©Šéšçãã¡ã¿ããŒã«ã§æœåºåŠçããçµç®åžå補å€äžã®ç¡é žã€
ãœãœã«ããã®æ®åéãé«é液äœã¯ãããã°ã©ãæ³ã«ãã枬å®ãããçµç®åžå補å€
ã®åœåã®ç¡é žã€ãœãœã«ããéãšè©ŠéšåŸã®æ®åéã®å·®ãïŒïŒæéã®ç®è移è¡éãšã
ãããããã·ã«ã ã®å Žåã¯ãçµç®åžå補å€ãã¯ãããã«ã ã§æœåºåŠçããçµç®åž
å補å€äžã®ãããã·ã«ã ã®æ®åéãé«é液äœã¯ãããã°ã©ãæ³ã«ãã枬å®ããŠã
ç¡é žã€ãœãœã«ããã®å Žåãšåæ§ã«ç®è移è¡éãæ±ããã
ã«çµç®åžå補å€ã®è©ŠéšçïŒé¢ç©ïŒïŒcm2ïŒã貌ä»ããïŒïŒæéåŸãããå¥é¢ããŠ
ååãããç¹°ãè¿ãåæ°ã¯å補å€æ¯ã«ïŒåãšãããè¬ç©ãç¡é žã€ãœãœã«ããã§ã
ãå Žåã¯ããããã®è©Šéšçãã¡ã¿ããŒã«ã§æœåºåŠçããçµç®åžå補å€äžã®ç¡é žã€
ãœãœã«ããã®æ®åéãé«é液äœã¯ãããã°ã©ãæ³ã«ãã枬å®ãããçµç®åžå補å€
ã®åœåã®ç¡é žã€ãœãœã«ããéãšè©ŠéšåŸã®æ®åéã®å·®ãïŒïŒæéã®ç®è移è¡éãšã
ãããããã·ã«ã ã®å Žåã¯ãçµç®åžå補å€ãã¯ãããã«ã ã§æœåºåŠçããçµç®åž
å補å€äžã®ãããã·ã«ã ã®æ®åéãé«é液äœã¯ãããã°ã©ãæ³ã«ãã枬å®ããŠã
ç¡é žã€ãœãœã«ããã®å Žåãšåæ§ã«ç®è移è¡éãæ±ããã
åçµç®åžå補å€ã«ã€ããŠã®ãŠãµã®ã®ç®èã«ãããè¬ç©ã®ç§»è¡éãè¡šïŒã«çºããŠ
瀺ãã
瀺ãã
è¡šïŒããæãããªããã«ãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³èªå°äœãšããª
ãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããå Žåãç®èåºæ¿ãçºçŸããé«æ¿åºŠã®ããªãª
ãã·ãšãã¬ã³èªå°äœãçšããå Žåãšåçã¬ãã«ä»¥äžã®è¬ç©ç§»è¡éãèªãããããiiïŒ ãŠãµã®ç®èåºæ¿æ§è©Šéš å®æœäŸïŒãïŒãïŒãïŒãïŒããã³æ¯èŒäŸïŒãïŒãïŒãïŒãïŒã®çµç®åžå補å€ã«
ã€ããŠãè©ŠéšïŒã«ç€ºãææ³ã«ãããŠãµã®ã®ç®èã«å¯Ÿããåºæ¿æ§è©Šéšãè¡ãªã£ãã
ãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããå Žåãç®èåºæ¿ãçºçŸããé«æ¿åºŠã®ããªãª
ãã·ãšãã¬ã³èªå°äœãçšããå Žåãšåçã¬ãã«ä»¥äžã®è¬ç©ç§»è¡éãèªãããããiiïŒ ãŠãµã®ç®èåºæ¿æ§è©Šéš å®æœäŸïŒãïŒãïŒãïŒãïŒããã³æ¯èŒäŸïŒãïŒãïŒãïŒãïŒã®çµç®åžå補å€ã«
ã€ããŠãè©ŠéšïŒã«ç€ºãææ³ã«ãããŠãµã®ã®ç®èã«å¯Ÿããåºæ¿æ§è©Šéšãè¡ãªã£ãã
è©ŠéšïŒ
è©ŠéšïŒãšåãææ³ã§åŠçãããŠãµã®ã®ç®èã«ã€ããŠãçµç®åžå補å€å¥é¢åŸãïŒ
æéåŸããã³ïŒïŒæéåŸã®ç®èã®çŽ æç¶æ ãç®èŠã§èŠ³å¯ããããªããæ¬è©Šéšã«ã
ããŠãæµ®è «ããã³çç®ã®åœ¢æã¯èªããããªãã£ãã
æéåŸããã³ïŒïŒæéåŸã®ç®èã®çŽ æç¶æ ãç®èŠã§èŠ³å¯ããããªããæ¬è©Šéšã«ã
ããŠãæµ®è «ããã³çç®ã®åœ¢æã¯èªããããªãã£ãã
çŽ
æã®çšåºŠã¯äžèšã®ïŒãïŒã®ïŒæ®µéã®å€å®åºæºã§è©äŸ¡ããã
ïŒâŠçŽ
æãªã
ïŒâŠãããããŠèå¥ã§ãã軜床ã®çŽ
æ
ïŒâŠæãããªçŽ
æ
ïŒâŠäžçšåºŠã®çŽ
æ
ïŒâŠæ·±çŽ
è²ã®åŒ·ãçŽ
æ
å¹³åå€ïŒååã«ãããè©ç¹ã®ç·åãç¹°ãè¿ãåæ°ïŒã§å²ã£ãå€ïŒãåã
ã®çµç®
åžå補å€ã®ç®èåºæ¿ææ°ãšãããåŸãããè©äŸ¡çµæãè¡šïŒã«ç€ºãã
åžå補å€ã®ç®èåºæ¿ææ°ãšãããåŸãããè©äŸ¡çµæãè¡šïŒã«ç€ºãã
è¡šïŒããæãããªããã«ãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³èªå°äœãšããª
ãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããå Žåãç®èåºæ¿ã¯æ®ã©èªããããªããiiiïŒ ç®èééæ§è©Šéš å®æœäŸïŒãïŒãïŒãïŒãïŒããã³æ¯èŒäŸïŒãïŒãïŒãïŒãïŒïŒã®çµç®åžå補å€
ã«ã€ããŠãè©ŠéšïŒã«ç€ºãææ³ã«ãããã¢ã¬ã¹ããŠã¹ã®æåºç®èã«å¯Ÿããè¬ç©ã®é
éæ§è©Šéšãè¡ãªã£ãã
ãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããå Žåãç®èåºæ¿ã¯æ®ã©èªããããªããiiiïŒ ç®èééæ§è©Šéš å®æœäŸïŒãïŒãïŒãïŒãïŒããã³æ¯èŒäŸïŒãïŒãïŒãïŒãïŒïŒã®çµç®åžå補å€
ã«ã€ããŠãè©ŠéšïŒã«ç€ºãææ³ã«ãããã¢ã¬ã¹ããŠã¹ã®æåºç®èã«å¯Ÿããè¬ç©ã®é
éæ§è©Šéšãè¡ãªã£ãã
è©ŠéšïŒ
ãŸããæ·»ä»å³é¢ã«ç€ºãæ¡æ£ã»ã«(ïŒ)ãæºåãããæ¡æ£ã»ã«(ïŒ)ã¯ãäžåŽã®æåº
åçç¶ã®ã¬ã»ãã¿ãŒæ§œ(ïŒ)ãšãããã®äžã«é 眮ãããæåºåçç¶ã®ãããŒæ§œ(ïŒ)
ãšãããªãããããŒæ§œ(ïŒ)ã®åºå£äžå€®ã«ã¯éå£éš(ïŒ)ãèšãããããŸããããŒæ§œ
(ïŒ)ã®äžç«¯ããã³ã¬ã»ãã¿ãŒæ§œ(ïŒ)ã®äžç«¯ã«ã¯ããããäžåŽãã©ã³ãž(ïŒ)ããã³
äžåŽãã©ã³ãž(ïŒ)ãèšããããŠããããããŠãäžåŽãã©ã³ãž(ïŒ)ãšäžåŽãã©ã³ãž
(ïŒ)ã察åç¶ã«éãåãããããšã«ãã£ãŠããããŒæ§œ(ïŒ)ãšã¬ã»ãã¿ãŒæ§œ(ïŒ)ã
æ°å¯ç¶ã«ãã€åå¿ç¶ã«ç©ã¿éããããŠãããã¬ã»ãã¿ãŒæ§œ(ïŒ)ã«ã¯ãã®åŽéšã«åŽ
æ¹çªåºç¶ã®ãµã³ããªã³ã°å£(ïŒ)ãåä»ããããã¬ã»ãã¿ãŒæ§œ(ïŒ)ã®å éšã«ã¯ãã°
ãããæ¹æå(ïŒ)ãå ¥ããŠããã
åçç¶ã®ã¬ã»ãã¿ãŒæ§œ(ïŒ)ãšãããã®äžã«é 眮ãããæåºåçç¶ã®ãããŒæ§œ(ïŒ)
ãšãããªãããããŒæ§œ(ïŒ)ã®åºå£äžå€®ã«ã¯éå£éš(ïŒ)ãèšãããããŸããããŒæ§œ
(ïŒ)ã®äžç«¯ããã³ã¬ã»ãã¿ãŒæ§œ(ïŒ)ã®äžç«¯ã«ã¯ããããäžåŽãã©ã³ãž(ïŒ)ããã³
äžåŽãã©ã³ãž(ïŒ)ãèšããããŠããããããŠãäžåŽãã©ã³ãž(ïŒ)ãšäžåŽãã©ã³ãž
(ïŒ)ã察åç¶ã«éãåãããããšã«ãã£ãŠããããŒæ§œ(ïŒ)ãšã¬ã»ãã¿ãŒæ§œ(ïŒ)ã
æ°å¯ç¶ã«ãã€åå¿ç¶ã«ç©ã¿éããããŠãããã¬ã»ãã¿ãŒæ§œ(ïŒ)ã«ã¯ãã®åŽéšã«åŽ
æ¹çªåºç¶ã®ãµã³ããªã³ã°å£(ïŒ)ãåä»ããããã¬ã»ãã¿ãŒæ§œ(ïŒ)ã®å éšã«ã¯ãã°
ãããæ¹æå(ïŒ)ãå ¥ããŠããã
ãã¢ã¬ã¹ããŠã¹ïŒïŒé±éœ¢ãéïŒãé æ€è±èŒã«ããå± æ®ºããåŸãçŽã¡ã«ç®èãå¥
é¢ããŠç®äžèèªãé€å»ããçŽïŒïœïœÃïŒïœïœã®ç®èçãåŸãããã®ç®èç(ïŒ)ã
æ¡æ£ã»ã«(ïŒ)ã®äžåŽãã©ã³ãž(ïŒ)ãšäžåŽãã©ã³ãž(ïŒ)ã®éã«æçããŠããããŒæ§œ
(ïŒ)ã®éå£éš(ïŒ)ãç®èç(ïŒ)ã§å®å šã«éããããã«ãããç®èç(ïŒ)ã®äžé¢ã«
ãçµç®åžå補å€ãé¢ç©ïŒïŒïŒïŒcm2ã®å圢ã«æã¡æããŠåŸãè©Šéšç(10)ã貌ä»ã
ããã¬ã»ãã¿ãŒæ§œ(ïŒ)ã«ã¯ãäžèšã®æ¹æ³ã«ãã調補ããã¬ã»ãã¿ãŒæ¶²ãæºããã
ã
é¢ããŠç®äžèèªãé€å»ããçŽïŒïœïœÃïŒïœïœã®ç®èçãåŸãããã®ç®èç(ïŒ)ã
æ¡æ£ã»ã«(ïŒ)ã®äžåŽãã©ã³ãž(ïŒ)ãšäžåŽãã©ã³ãž(ïŒ)ã®éã«æçããŠããããŒæ§œ
(ïŒ)ã®éå£éš(ïŒ)ãç®èç(ïŒ)ã§å®å šã«éããããã«ãããç®èç(ïŒ)ã®äžé¢ã«
ãçµç®åžå補å€ãé¢ç©ïŒïŒïŒïŒcm2ã®å圢ã«æã¡æããŠåŸãè©Šéšç(10)ã貌ä»ã
ããã¬ã»ãã¿ãŒæ§œ(ïŒ)ã«ã¯ãäžèšã®æ¹æ³ã«ãã調補ããã¬ã»ãã¿ãŒæ¶²ãæºããã
ã
ã€ãã§æ¡æ£ã»ã«(ïŒ)ã枩床ïŒïŒÂ°ã«ä¿ãããæ枩槜å
ã«èšçœ®ãããã°ãããæª
æè£ çœ®ã«ããã¬ã»ãã¿ãŒæ¶²ã®æ¹æãè¡ãªã£ããè©Šéšéå§ïŒïŒæéåŸãµã³ããªã³ã°
å£(ïŒ)ããã¬ã»ãã¿ãŒæ¶²ïŒïœïœãæ¡åãããã®ã¬ã»ãã¿ãŒæ¶²ãžã®è¬ç©ã®éééã
é«é液äœã¯ãããã°ã©ãæ³ã«ãã枬å®ãããåçµç®åžå補å€å€ã«ã€ããŠã®ééé
枬å®å€ãè¡šïŒã«çºããŠç€ºãã
æè£ çœ®ã«ããã¬ã»ãã¿ãŒæ¶²ã®æ¹æãè¡ãªã£ããè©Šéšéå§ïŒïŒæéåŸãµã³ããªã³ã°
å£(ïŒ)ããã¬ã»ãã¿ãŒæ¶²ïŒïœïœãæ¡åãããã®ã¬ã»ãã¿ãŒæ¶²ãžã®è¬ç©ã®éééã
é«é液äœã¯ãããã°ã©ãæ³ã«ãã枬å®ãããåçµç®åžå補å€å€ã«ã€ããŠã®ééé
枬å®å€ãè¡šïŒã«çºããŠç€ºãã
ã¬ã»ãã¿ãŒæ¶²ã®èª¿è£œæ³
ïœïŒš24ïŒïŒÃïŒïŒ-4ã¢ã«ïŒãïœ24ïŒïŒÃïŒïŒ-4ã¢ã«ïŒãïœïŒ£
ïœïŒïŒïŒïŒÃïŒïŒ-1ã¢ã«ïŒããã³ã²ã³ã¿ãã€ã·ã³ïŒïŒïœïœãèžçæ°ŽïŒïŒïŒïœïœã«
溶ãããåŸããã溶液ã®ïœïŒšãïŒïŒïŒèŠå®ïŒ®ïœïŒ¯ïŒšæ°Žæº¶æ¶²ã§ïŒïŒïŒã«èª¿æŽããåŸ
ããã®å®¹éãèžçæ°Žã§ïŒïŒïŒïŒïœïœãšããã
ïœïŒïŒïŒïŒÃïŒïŒ-1ã¢ã«ïŒããã³ã²ã³ã¿ãã€ã·ã³ïŒïŒïœïœãèžçæ°ŽïŒïŒïŒïœïœã«
溶ãããåŸããã溶液ã®ïœïŒšãïŒïŒïŒèŠå®ïŒ®ïœïŒ¯ïŒšæ°Žæº¶æ¶²ã§ïŒïŒïŒã«èª¿æŽããåŸ
ããã®å®¹éãèžçæ°Žã§ïŒïŒïŒïŒïœïœãšããã
è¡šïŒããæãããªããã«ãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³èªå°äœã«ããª
ãšãã¬ã³ã°ãªã³ãŒã«ã䜵çšããå Žåã«ã¯ãããªãšãã¬ã³ã°ãªã³ãŒã«ãçšããªãå Ž
åã«æ¯ã¹ãç®èéééãèããé«ããªãããšãèªãããããivïŒ ããç®è移è¡æ§è©Šéš å®æœäŸïŒããã³æ¯èŒäŸïŒã®çµç®åžå補å€ã«ã€ããŠãè©ŠéšïŒã«ç€ºãææ³ã«ããã
ãã®ç®èã«å¯Ÿããè¬ç©ã®ç§»è¡æ§è©Šéšãè¡ãªã£ãã
ãšãã¬ã³ã°ãªã³ãŒã«ã䜵çšããå Žåã«ã¯ãããªãšãã¬ã³ã°ãªã³ãŒã«ãçšããªãå Ž
åã«æ¯ã¹ãç®èéééãèããé«ããªãããšãèªãããããivïŒ ããç®è移è¡æ§è©Šéš å®æœäŸïŒããã³æ¯èŒäŸïŒã®çµç®åžå補å€ã«ã€ããŠãè©ŠéšïŒã«ç€ºãææ³ã«ããã
ãã®ç®èã«å¯Ÿããè¬ç©ã®ç§»è¡æ§è©Šéšãè¡ãªã£ãã
è©ŠéšïŒ
å®æœäŸïŒããã³æ¯èŒäŸïŒã®çµç®åžå補å€ã®åè©ŠéšçïŒé¢ç©ïŒïŒcm2ïŒãããã
ã被éšè ïŒç·æ§å¥åžžäººïŒã®äžè éšã«è²Œä»ããïŒïŒæéåŸã«ããããå¥é¢ããŠåå
ããããããã®è©Šéšçãã¡ã¿ããŒã«ã§æœåºåŠçããçµç®åžå補å€äžã®ç¡é žã€ãœãœ
ã«ããã®æ®åéãé«é液äœã¯ãããã°ã©ãæ³ã«ãã枬å®ãããè©Šéšã¯åçµç®åžå
補å€æ¯ã«ïŒåã®è¢«éšè ã§è¡ãªããçµç®åžå補å€ã®åœåã®è¬ç©éãšè©ŠéšåŸã®æ®åé
ã®å·®ãïŒïŒæéã®ç®è移è¡éãšãããããã®å¹³åããšã£ããåçµç® åžå補å€ã«ã€ããŠã®ããã®ç®èã«ãããè¬ç©ã®ç§»è¡éãè¡šïŒã«ç€ºãã
ã被éšè ïŒç·æ§å¥åžžäººïŒã®äžè éšã«è²Œä»ããïŒïŒæéåŸã«ããããå¥é¢ããŠåå
ããããããã®è©Šéšçãã¡ã¿ããŒã«ã§æœåºåŠçããçµç®åžå補å€äžã®ç¡é žã€ãœãœ
ã«ããã®æ®åéãé«é液äœã¯ãããã°ã©ãæ³ã«ãã枬å®ãããè©Šéšã¯åçµç®åžå
補å€æ¯ã«ïŒåã®è¢«éšè ã§è¡ãªããçµç®åžå補å€ã®åœåã®è¬ç©éãšè©ŠéšåŸã®æ®åé
ã®å·®ãïŒïŒæéã®ç®è移è¡éãšãããããã®å¹³åããšã£ããåçµç® åžå補å€ã«ã€ããŠã®ããã®ç®èã«ãããè¬ç©ã®ç§»è¡éãè¡šïŒã«ç€ºãã
è¡šïŒããæãããªããã«ããŠãµã®ã®ç®èã«å¯Ÿããè¬ç©ç§»è¡æ§ãšåããããã®ç®
èã«å¯Ÿããè¬ç©ç§»è¡æ§ã«ã€ããŠããåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³èªå°äœ
ãšããªãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããå Žåã¯ãç®èåºæ¿ãçºçŸããé«æ¿åºŠ
ã®ããªãªãã·ãšãã¬ã³èªå°äœãçšããå Žåãšåçã¬ãã«ä»¥äžã®è¬ç©ç§»è¡éãèªã
ããããïœïŒ ããç®èåºæ¿æ§è©Šéš å®æœäŸïŒããã³æ¯èŒäŸïŒã®çµç®åžå補å€ã«ã€ããŠãè©ŠéšïŒã«ç€ºãææ³ã«ããã
ãã®ç®èã«å¯Ÿããåºæ¿æ§è©Šéšãè¡ãªã£ãã
èã«å¯Ÿããè¬ç©ç§»è¡æ§ã«ã€ããŠããåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³èªå°äœ
ãšããªãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããå Žåã¯ãç®èåºæ¿ãçºçŸããé«æ¿åºŠ
ã®ããªãªãã·ãšãã¬ã³èªå°äœãçšããå Žåãšåçã¬ãã«ä»¥äžã®è¬ç©ç§»è¡éãèªã
ããããïœïŒ ããç®èåºæ¿æ§è©Šéš å®æœäŸïŒããã³æ¯èŒäŸïŒã®çµç®åžå補å€ã«ã€ããŠãè©ŠéšïŒã«ç€ºãææ³ã«ããã
ãã®ç®èã«å¯Ÿããåºæ¿æ§è©Šéšãè¡ãªã£ãã
è©ŠéšïŒ
è©ŠéšïŒã®ææ³ã«ãããŠãçµç®åžå補å€å¥é¢åŸãïŒæéåŸããã³ïŒïŒæéåŸã®ç®
èã®çŽ æç¶æ ãç®èŠã§èŠ³å¯ããããªããæ¬è©Šéšã«ãããŠããæµ®è «ããã³çç®ã®åœ¢
æã¯èªããããªãã£ãã
èã®çŽ æç¶æ ãç®èŠã§èŠ³å¯ããããªããæ¬è©Šéšã«ãããŠããæµ®è «ããã³çç®ã®åœ¢
æã¯èªããããªãã£ãã
çŽ
æã®å€å®åºæºã¯è©ŠéšïŒã§ç€ºããéãã§ããã
ïŒåã®è©ç¹ã®å¹³åå€ãåã
ã®çµç®åžå補å€ã®ç®èåºæ¿ææ°ãšãããåŸãããè©
䟡çµæãè¡šïŒã«ç€ºãã
䟡çµæãè¡šïŒã«ç€ºãã
è¡šïŒããæãããªããã«ãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³èªå°äœãšããª
ãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããå Žåãããã®ç®èã«å¯Ÿããåºæ¿ã¯æ®ã©èªã
ãããªãã
ãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããå Žåãããã®ç®èã«å¯Ÿããåºæ¿ã¯æ®ã©èªã
ãããªãã
ïŒçºæã®å¹æïŒ
æ¬çºæã«ããçµç®åžå補å€ã¯ãåžåä¿é²å€ãšããŠããªãªãã·ãšãã¬ã³èªå°äœãš
ããªãšãã¬ã³ã°ãªã³ãŒã«ã®çµã¿åãããçšãããã®ã§ããã®ã§ãææã®è¬å¹ãçº
çŸãããã«å åãªéã®è¬ç©ãç®èãçµãŠåžåããããããšãã§ãããšå ±ã«ãåžå
ä¿é²å€ã«ããç®èåºæ¿ã倧巟ã«äœæžããããšãã§ããã
ããªãšãã¬ã³ã°ãªã³ãŒã«ã®çµã¿åãããçšãããã®ã§ããã®ã§ãææã®è¬å¹ãçº
çŸãããã«å åãªéã®è¬ç©ãç®èãçµãŠåžåããããããšãã§ãããšå ±ã«ãåžå
ä¿é²å€ã«ããç®èåºæ¿ã倧巟ã«äœæžããããšãã§ããã
ãã®ãããªæ¬çºæã®é¡èãªå¹æã¯ãããªãªãã·ãšãã¬ã³èªå°äœãšããªãšãã¬ã³
ã°ãªã³ãŒã«ãšãããªãåžåä¿é²å€ã®ã€ãã®ãããªäœçšæ©åºã«ãããã®ãšèããã
ãã
ã°ãªã³ãŒã«ãšãããªãåžåä¿é²å€ã®ã€ãã®ãããªäœçšæ©åºã«ãããã®ãšèããã
ãã
ïŒïœïŒ æ¬åžåä¿é²å€ã®äœ¿çšã«ãããåäœé¢ç©ããã³åäœæéåœããã®è¬ç©ã®æŸ
åºéããã³ç®èå éšãžã®è¬ç©ã®ç§»è¡æ§ã極ããŠåäžãããããããã¯ãäžèšç©è³ª
ãç²çæ§åºå€ã®ç©æ§ãå€ãããšå ±ã«ãç®èå ã«æµžéããŠè§è³ªå±€ã®ç©çååŠçæ§è³ª
ãå€ããŠè§è³ªå±€ã®ããªã€ãŒæ©èœãæžéãããããã§ããããã®çµæãç²çæ§åºå€
ãšç®èã®éã®è¬ç©ã®åé ä¿æ°ãå€åãããããã¯ãç®èäžã«ãããè¬ç©ã®æ¡æ£é
床ãé«ããããè¬ç©ã®æŸåºéãåäžãããšå ±ã«ãæèŠéã®è¬ç©ã容æã«ç®èãé
éããŠäœå 埪ç°åšç³»ã«åžåãããã
åºéããã³ç®èå éšãžã®è¬ç©ã®ç§»è¡æ§ã極ããŠåäžãããããããã¯ãäžèšç©è³ª
ãç²çæ§åºå€ã®ç©æ§ãå€ãããšå ±ã«ãç®èå ã«æµžéããŠè§è³ªå±€ã®ç©çååŠçæ§è³ª
ãå€ããŠè§è³ªå±€ã®ããªã€ãŒæ©èœãæžéãããããã§ããããã®çµæãç²çæ§åºå€
ãšç®èã®éã®è¬ç©ã®åé ä¿æ°ãå€åãããããã¯ãç®èäžã«ãããè¬ç©ã®æ¡æ£é
床ãé«ããããè¬ç©ã®æŸåºéãåäžãããšå ±ã«ãæèŠéã®è¬ç©ã容æã«ç®èãé
éããŠäœå 埪ç°åšç³»ã«åžåãããã
ãã®ãããåŸæ¥ã®è¬ç©å«æçµç®åžå補å€ãšæ¯èŒããŠãåäžé¢ç©ã®åŸæ¥åããã
æå¹æäžéã®å€§ããªçµç®åžå補å€ãåŸãããšãã§ãããæèšããã°ãåŸæ¥åãã
å°ããé¢ç©ã®çµç®åžå補å€ã§åŸæ¥åãšåäžã®å¹æãåŸãããšãã§ããã
æå¹æäžéã®å€§ããªçµç®åžå補å€ãåŸãããšãã§ãããæèšããã°ãåŸæ¥åãã
å°ããé¢ç©ã®çµç®åžå補å€ã§åŸæ¥åãšåäžã®å¹æãåŸãããšãã§ããã
ïŒïœïŒ ç®èåºæ¿ã®äœæžã«ã€ããŠã¯ãæ¬åžåä¿é²å€ã¯ãäžèšã®åŠããåªããçµ
ç®ééä¿é²å¹æã瀺ãç©è³ªã§ããã®ã§ãè¬ç©æäžã«å¿
èŠãªè²Œä»é¢ç©ãå°ãããŠ
ãã¿ãé·æ䜿çšã«éããŠç®èã®ãã¡ãŒãžãå°ãªãã
ãã¿ãé·æ䜿çšã«éããŠç®èã®ãã¡ãŒãžãå°ãªãã
ãŸããäžèšã®ããã«å°ããé¢ç©ã®çµç®åžå補å€ã§å
åãªè¬å¹ãåŸãããããã
ç®èåºæ¿ã«ææãªäººã«ãããŠãçŽ æãçããããšãåé¿ããããããŸãã¯çŽ æã®
é¢ç©ãå¯åçã«çž®å°ããããããããŠãã®ããã«çµç®åžå補å€ãå°é¢ç©ã§ããã
ãã貌ä»æäœã容æã«ãªãåŸãäžã«ã貌ä»ã«ããéåæãå°ãªãããããšãã§ã
ãã
ç®èåºæ¿ã«ææãªäººã«ãããŠãçŽ æãçããããšãåé¿ããããããŸãã¯çŽ æã®
é¢ç©ãå¯åçã«çž®å°ããããããããŠãã®ããã«çµç®åžå補å€ãå°é¢ç©ã§ããã
ãã貌ä»æäœã容æã«ãªãåŸãäžã«ã貌ä»ã«ããéåæãå°ãªãããããšãã§ã
ãã
ïŒïœïŒ ããã«ãæ¬åžåä¿é²å€ã¯ãäžèšã®åŠããææã®è¬å¹ãçºçŸãããã®ã«å
åãªéã®è¬ç©ã容æã«çµç®çã«åžåããããããåŸæ¥ã®ããã«å€§éã®è¬ç©ã貌ä»
å±€ã«å«æãããå¿ èŠããªãã
åãªéã®è¬ç©ã容æã«çµç®çã«åžåããããããåŸæ¥ã®ããã«å€§éã®è¬ç©ã貌ä»
å±€ã«å«æãããå¿ èŠããªãã
ãŸããæ¬åžåä¿é²å€ã®äœ¿çšã«ãããæå¹è¡äžæ¿åºŠãé·æéã«ããã£ãŠç¶æãã
ããšãã§ããè¬ç©ã®ãã€ãªã¢ãã€ã©ããªãã£ãé«ããããšãã§ããã
ããšãã§ããè¬ç©ã®ãã€ãªã¢ãã€ã©ããªãã£ãé«ããããšãã§ããã
ãŸããæ¬åžåä¿é²å€ã¯ãè¬ç©ãå€æ§ãããããšããªããç²çæ§åºå€ãšã®çžæº¶æ§
ã«ãåªããã€è¬ç©ãšç²çæ§åºå€ãšã®çžæº¶æ§ã«å€åãäžããªããããçµç®åžå補å€
è¡šé¢ããè¬ç©ãæåºããããšããªãã
ã«ãåªããã€è¬ç©ãšç²çæ§åºå€ãšã®çžæº¶æ§ã«å€åãäžããªããããçµç®åžå補å€
è¡šé¢ããè¬ç©ãæåºããããšããªãã
ïŒïœïŒ ããããŠãæ¬çºæã®çµç®åžå補å€ã«ããã°ãåžåä¿é²å€ãšããŠããªãªã
ã·ãšãã¬ã³èªå°äœãšããªãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããã®ã§ãäžèšã®åŠã
ç¹æã®é¡èãªå¹æãçºæ®ããããã
ã·ãšãã¬ã³èªå°äœãšããªãšãã¬ã³ã°ãªã³ãŒã«ã®äœµçšç³»ãçšããã®ã§ãäžèšã®åŠã
ç¹æã®é¡èãªå¹æãçºæ®ããããã
å³é¢ã¯çµç®åžå補å€ã«å«ãŸããè¬ç©ã®ç®èééæ§ãè©Šéšããã®ã«äœ¿çšãããæ¡
æ£ã»ã«ã瀺ãæèŠå³ã§ããã
æ£ã»ã«ã瀺ãæèŠå³ã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã (ïŒ) éæ°Žç³»ç²çæ§åºå€ãšåžåä¿é²å€ãšè¬ç©ãšãããªã貌ä»å±€ãæ¯æäœäžã«ä¿
æããŠãªãçµç®åžå補å€ã«ãããŠã該åžåä¿é²å€ãããªãªãã·ãšãã¬ã³èªå°äœãš
ããªãšãã¬ã³ã°ãªã³ãŒã«ãšãããªãããšãç¹åŸŽãšããçµç®åžå補å€ã (ïŒ) 貌ä»å±€äžã®åžåä¿é²å€ã®é åéãïŒïŒïŒãïŒïŒééïŒ ã§ããè«æ±é ïŒèš
èŒã®è£œå€ã
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004509222A (ja) | çµç®è¬ç©ééã·ã¹ãã ã«ãããŠæçšãªéåå¿åæ¥çå€ | |
JP2507158B2 (ja) | çµç®åžåè£œå€ | |
CA2041330C (en) | Percutaneously absorbable eperisone or tolperisone preparation | |
JP2503095B2 (ja) | 貌ä»å€ | |
JP3276194B2 (ja) | å»ççšè²Œä»å€ | |
JPH1045571A (ja) | 貌ä»å€ | |
JPH06145050A (ja) | 貌ä»å€ã®è£œé æ¹æ³ | |
JPH11209271A (ja) | çµç®åžåè£œå€ | |
JP3197039B2 (ja) | ããŒãè£œå€ | |
JPH0413617A (ja) | 貌ä»å€ | |
JPH0753671B2 (ja) | çµç®ã»çµç²èè£œå€ | |
JPH10306023A (ja) | çµç®åžå補å€åã³ãã®è£œé æ¹æ³ | |
JPH0543457A (ja) | çµç®åžåè£œå€ | |
JP3027018B2 (ja) | å»ççšè²Œä»å€ | |
JPH07165563A (ja) | ããŒãè£œå€ | |
JPH05186371A (ja) | çµç®åžåè£œå€ | |
JPH04202140A (ja) | çµç®åžåè£œå€ | |
JP2507158C (ja) | ||
JP3224582B2 (ja) | çµç®åžåè£œå€ | |
JP3192765B2 (ja) | ããŒãè£œå€ | |
JP3130350B2 (ja) | çµç®åžåè£œå€ | |
JPH09278651A (ja) | çµç®åžå貌ä»å€ | |
JPH08104625A (ja) | 貌ä»å€ | |
JP3176400B2 (ja) | è¬ç©ã®è¡šç®çŽ°èå±€ééä¿é²å€ããã³çµç®åžåè£œå€ | |
JPS62240613A (ja) | 貌ä»å€ |